Abst,Sent,Source,Output,Simp. sent,Simp. term,Simp. term acc.,Simp. fluency
Q1_A4,1,Purpose: To determine predictors of best-corrected postoperative visual acuity (VA) in patients who underwent surgical intervention for macula-off rhegmatogenous retinal detachment.,Goal: To identify factors that can predict how well patients' eyesight will be after surgery for a particular type of retinal detachment.,1,0,1,1
Q1_A4,2,Materials and methods: Primary macula-off retinal detachments from the University of Colorado Primary Rhegmatogenous Retinal Detachment Database (2012-2017) were reviewed.,"Materials and methods: We looked at data from patients with a specific type of retinal detachment who were treated at the University of Colorado between 2012 and 2017. The size of the detachment, the condition of the macula, and the patients' eyesight before surgery were all important factors in determining how well they could see six months after surgery. By looking at certain factors before surgery, doctors can give patients a better idea of how well their eyesight will be after the operation.",1,0,1,0
Q1_A4,3,The primary outcome measure was a postoperative VA of 20/40 or better at least 6 months after surgery.,The main goal was to see if patients had at least 20/40 vision or better six months after surgery.,1,1,1,1
Q1_A4,4,"Patient demographics, medical history, duration of central vision loss before surgery, examination findings, operative technique, and postoperative findings were analyzed as possible predictors of postoperative visual recovery to 20/40 or better.","We looked at patient information like age, medical history, how long they had vision loss, and the results of their eye exams, surgery, and recovery to see if these factors could predict if they would have 20/40 vision or better after surgery.",1,1,1,1
Q1_A4,5,"Chi-square or Fisher's exact test was used to compare categorical variables, and Wilcoxon rank sum test was used for continuous variables.","We used statistical tests to compare different types of information, like whether patients had certain characteristics or if they had different results from their eye exams, surgeries, and recoveries.",0,0,1,1
Q1_A4,6,A multivariable logistic regression analysis was used to determine the adjusted odds ratios and 95% confidence intervals for variables that were significant in the univariable analyses.,We calculated the odds ratios and confidence intervals for factors that were found to be important in our analysis.,1,-1,0,1
Q1_A4,7,Statistical significance was set at p < 0.05.,We considered results to be statistically significant if the probability of them occurring by chance was less than 5%.,0,0,1,1
Q1_A4,8,Results: One hundred thirty-one patients met inclusion criteria.,Results: 131 patients were included in the study.,1,1,1,1
Q1_A4,9,Eighty-one (61.8%) patients achieved a postoperative VA of 20/40 or better 6 or more months after surgery.,Results: 81 out of 131 patients (about 62%) had vision of 20/40 or better six months after surgery.,1,0,0,1
Q1_A4,10,"Patients with a single retinal break were more likely than patients with more than one break to reach a postoperative VA of 20/40 or better (76.9% vs. 55.4%, p = 0.021).","Patients who had only one retinal break were more likely to have 20/40 vision or better after surgery compared to patients who had more than one break (76.9% vs. 55.4%, with a p-value of 0.021).",0,0,1,1
Q1_A4,11,Patients with a better preoperative logMAR VA had better postoperative VA (p = 0.021).,Patients who had better eyesight before surgery were more likely to have better eyesight after surgery (p = 0.021).,0,1,1,1
Q1_A4,12,Duration of central vision loss prior to surgical repair was not related to final postoperative VA in this particular study.,The length of time a patient experienced vision loss before surgery did not affect their eyesight after surgery in this study.,1,1,1,1
Q1_A4,13,Conclusion: Postoperative recovery of visual acuity to 20/40 or better was significantly more common in patients with a single retinal break as well as in patients with better preoperative visual acuity.,"In conclusion, patients who had only one retinal break and better eyesight before surgery were more likely to have good eyesight after their operation.",1,1,1,1
Q1_A4,14,Duration of central vision loss prior to surgical repair was not significantly associated with postoperative VA.,The amount of time a patient experienced vision loss before surgery did not have a significant impact on their eyesight after the operation.,0,0,0,1
Q2_A6,1,Background: Our primary objective was to determine the rate of persistent Trichomonas infection among pregnant women posttreatment.,Background: We wanted to find out how common it is for pregnant women to still have a Trichomonas infection after receiving treatment.,1,1,1,1
Q2_A6,2,The secondary objective was to determine if oral multidose metronidazole was associated with fewer cases of persistent Trichomonas compared with single-dose treatment.,Secondary Objective: We also wanted to see if taking multiple doses of metronidazole orally would be more effective in preventing persistent Trichomonas infection compared to just taking a single dose.,0,0,1,1
Q2_A6,3,Methods: This is a retrospective cohort study of women diagnosed with genital Trichomonas vaginalis from 2008 to 2017.,Methods: We looked at data from women with a Trichomonas vaginalis infection between 2008 and 2017 to conduct our study.,1,0,1,1
Q2_A6,4,We calculated the rate of persistent Trichomonas by dividing the number of positive Trichomonas tests collected 21 days or longer posttreatment by the total number of women treated and retested.,We calculated the rate of persistent Trichomonas infection by dividing the number of women who still tested positive for Trichomonas 21 days or more after treatment by the total number of women who were treated and retested.,-1,0,1,1
Q2_A6,5,Bivariate analysis was performed to compare the rates of positive tests after single and multidose metronidazole.,We conducted an analysis to compare the rates of positive test results for Trichomonas after treatment with both single and multiple doses of metronidazole.,0,0,1,1
Q2_A6,6,Multivariate logistic regression was used to evaluate factors associated with persistent infection.,We used multivariate logistic regression to analyze factors that may be linked to persistent infection.,1,-1,1,1
Q2_A6,7,Results: Five hundred forty-two women with 565 pregnancies were diagnosed with Trichomonas infection.,Results: We found that 542 women with a total of 565 pregnancies had a Trichomonas infection.,1,1,1,1
Q2_A6,8,The majority of subjects were prescribed either single-dose (n = 352) or multidose metronidazole (n = 74).,The majority of women were given either a single dose (352) or multiple doses (74) of metronidazole.,1,0,1,1
Q2_A6,9,Posttreatment Trichomonas tests were collected 21 days or longer in 326 subjects and 44% (143) were positive.,"After treatment, we collected Trichomonas tests from 326 women at least 21 days later, and found that 44% of them (143 women) still tested positive for the infection.",0,1,1,1
Q2_A6,10,"Rates of positive Trichomonas tests among women receiving single-dose and multidose regimens were similar (45% vs. 40%, P = 0.50).","The rates of positive Trichomonas tests were about the same for women who received a single dose or multiple doses of medication (45% vs. 40%, P = 0.50).",0,0,1,1
Q2_A6,11,"Women who had ≥1 pregnancy affected by Trichomonas infection were more likely to have a positive test posttreatment (adjusted odds ratio, 20.1; 95% confidence interval, 1.9-215.3).","Women who had at least one pregnancy affected by Trichomonas infection were much more likely to still have a positive test for the infection after treatment (adjusted odds ratio, 20.1; 95% confidence interval, 1.9-215.3).",0,0,1,1
Q2_A6,12,"Obese women were less likely to have a positive test posttreatment (adjusted odds ratio, 0.3; 95% confidence interval, 0.1-0.9).","Simple: Women who were obese were less likely to still have a positive test for the infection after treatment (adjusted odds ratio, 0.3; 95% confidence interval, 0.1-0.9).",-1,0,1,0
Q2_A6,13,"Conclusions: Given high rates of positive Trichomonas tests and increased detection with nucleic acid amplification tests (NAATs), all pregnant women should be retested with NAATs approximately 3 weeks posttreatment.","Conclusion: Since we found a high rate of positive Trichomonas tests, especially with more sensitive tests, we recommend that all pregnant women should be tested again with these more sensitive tests about 3 weeks after treatment.",0,1,1,1
Q2_A6,14,Further studies are needed to determine the most effective treatment of Trichomonas infection in pregnant women.,More research is needed to find the best treatment for Trichomonas infection in pregnant women.,1,1,1,1
Q3_A10,1,Objective: To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC).,Goal: To determine how a new birth control pill affects blood clotting.,1,1,1,1
Q3_A10,2,"Study design: In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DRSP) (n = 39), 30 mcg ethinylestradiol/150 mcg levonorgestrel (EE/LNG) (n = 30), or 20 mcg ethinylestradiol/3 mg drospirenone (EE/DRSP) (n = 32) for six 28-day cycles.","Study Design: In this study, healthy women were randomly assigned to receive either a new birth control pill containing 15 mg estetrol and 3 mg drospirenone, a commonly used birth control pill containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel, or another commonly used birth control pill containing 20 mcg ethinylestradiol and 3 mg drospirenone. They took the pills for six cycles, each lasting 28 days.",1,1,1,1
Q3_A10,3,"Blood was collected at baseline, cycle 3, and cycle 6.",Blood samples were collected at the beginning of the study and at the third and sixth cycles.,1,1,1,1
Q3_A10,4,"Median change from baseline was evaluated for procoagulant, anticoagulant, and fibrinolytic parameters, and for sex hormone-binding globulin (SHBG).","We looked at the average changes in blood clotting, blood thinning, and blood clot breakdown, as well as the levels of sex hormone-binding globulin, compared to the beginning of the study.",1,1,1,1
Q3_A10,5,"Results: Median change of endogenous thrombin potential (ETP) based activated protein C sensitivity resistance (APCr) at cycle 6 was +30% for E4/DRSP, +165% for EE/LNG (p-value <0.05 vs E4/DRSP), and +219% for EE/DRSP (p-value <0.05 vs E4/DRSP).","Results: At the end of the study, the average increase in blood clotting was 30% for women taking the new birth control pill, 165% for women taking the commonly used birth control pill, and 219% for women taking another commonly used birth control pill. These increases were statistically significant compared to the new birth control pill.",1,1,1,1
Q3_A10,6,"Changes to prothrombin fragment 1 + 2 and SHBG for E4/DRSP, EE/LNG, and EE/DRSP were +23%, +71%, and +64% (p-value <0.05 vs E4/DRSP); and +55%, +74% and +251% (p-value <0.05 vs E4/DRSP), respectively.","Changes in blood clotting markers and sex hormone-binding globulin levels were observed in women taking the different birth control pills. These changes varied depending on the type of pill, with some pills causing larger increases in blood clotting and sex hormone-binding globulin compared to others.",1,1,1,1
Q3_A10,7,"At cycle 6, changes to other hemostasis parameters for E4/DRSP were similar or smaller than for EE/LNG or EE/DRSP.","By the sixth cycle of the study, the changes in other blood clotting parameters were similar or smaller in women taking the new birth control pill compared to the other commonly used birth control pills.",1,1,1,1
Q3_A10,8,"Conclusions: In this study, changes in hemostasis parameters after treatment with 6 cycles of E4/DRSP were smaller or similar to those observed for EE/LNG.",Conclusions: This study found that the new birth control pill had similar or smaller effects on blood clotting compared to the commonly used birth control pill.,1,1,1,1
Q3_A10,9,"Similar, but more pronounced changes were also observed versus EE/DRSP, which supports the hypothesis that the effect of COCs on hemostasis parameters is mainly mediated by the estrogenic component.","Similar, but stronger changes were also seen compared to the other commonly used birth control pill, which suggests that the estrogen in birth control pills is the main factor affecting blood clotting.",1,1,1,1
Q3_A10,10,Further studies are needed to provide more insight into the venous thromboembolic risk of E4/DRSP.,More studies are needed to understand the risk of blood clots with the new birth control pill.,1,1,1,1
Q3_A10,11,Implications statement: This study reports that the effects on hemostasis parameters of a COC containing 15 mg E4/3 mg DRSP are less or similar to those for EE/LNG or EE/DRSP.,Implications: This study found that the new birth control pill has similar or smaller effects on blood clotting compared to other commonly used birth control pills.,1,1,1,1
Q3_A10,12,It also demonstrates that the choice of estrogen modulates the effects of COCs on hemostasis parameters.,It also shows that the type of estrogen in birth control pills affects how they affect blood clotting.,1,1,1,1
Q4_A4,1,"Purpose: This study investigated the prevalence, location, and severity of neck and shoulder pain (NSP), its disturbance of quality of life (QOL), and the factors related to NSP in Japanese postpartum women.","The purpose of this study was to understand how common and severe neck and shoulder pain is among Japanese women after giving birth, and how it affects their quality of life. The researchers also wanted to identify any factors that might contribute to this pain.",1,1,1,1
Q4_A4,2,Materials and methods: The study involved 308 postpartum women who had a medical examination one month after delivery.,"For this study, researchers looked at 308 women who had given birth and had a medical check-up one month later. Original: Results: Neck and shoulder pain was experienced by 61.4% of the women, with the highest severity in the neck area. The pain had a negative impact on the women's quality of life. Factors such as age, history of NSP, and work-related factors were found to be associated with NSP. Simple: The study found that 61.4% of the women experienced neck and shoulder pain, with the most intense pain in the neck area. This pain had a negative impact on their quality of life. The researchers also discovered that factors such as age, previous history of neck and shoulder pain, and work-related factors were linked to this pain.",1,1,1,1
Q4_A4,3,The questionnaire consisted of the background and details of NSP.,The questionnaire asked about the participant's background and specific information about their neck and shoulder pain.,1,1,1,1
Q4_A4,4,"Mood states were evaluated using the Profile of Mood States-Brief (POMS-B), Japanese Version.","The researchers used a questionnaire called the Profile of Mood States-Brief (POMS-B), Japanese Version, to measure the participants' mood.",1,1,1,1
Q4_A4,5,"Results: The prevalence of NSP was 73.1%, one-fourth of which occurred after birth.","The study found that 73.1% of the participants experienced neck and shoulder pain, with a quarter of them experiencing this pain after giving birth.",1,1,1,1
Q4_A4,6,The most common area was the superior part of the trapezium muscles.,The most common area for pain was the upper part of the trapezius muscles.,1,0,1,1
Q4_A4,7,"Prevalence was associated with past history of premenstrual syndrome (PMS), anemia during pregnancy, time per breastfeeding, and the mean POMS-B Fatigue score.","The researchers found that the prevalence of neck and shoulder pain was linked to factors such as a previous history of premenstrual syndrome (PMS), anemia during pregnancy, the amount of time spent breastfeeding, and the participants' average score for fatigue on the POMS-B questionnaire.",0,1,1,1
Q4_A4,8,"Total breastfeeding time a day, the mean POMS-B score for Fatigue, Confusion, Anger-Hostility, and Depression were significantly higher for ""worse"" after birth than those for ""no-change/relief"".","Mothers who experienced worse neck and shoulder pain after giving birth breastfed for more time each day and had higher scores for fatigue, confusion, anger-hostility, and depression on the questionnaire compared to those who did not experience any changes or felt relief from their pain.",-1,1,1,1
Q4_A4,9,The disturbance of daily life due to NSP in postpartum women with past history of PMS and Hiesho were significant higher than that for women without those.,Postpartum women who had a history of premenstrual syndrome (PMS) and anemia during pregnancy experienced more disruption in their daily lives due to neck and shoulder pain compared to women without these conditions.,0,1,0,1
Q4_A4,10,Conclusions: The prevalence of NSP in postpartum women was very high.,"In conclusion, a large number of postpartum women experience neck and shoulder pain.",1,0,1,1
Q4_A4,11,"The factors which affect NSP were the mental states, breastfeeding, past history of PMS, and anemia during pregnancy.","The factors that contribute to neck and shoulder pain in postpartum women are their mental state, breastfeeding, previous history of premenstrual syndrome (PMS), and anemia during pregnancy.",0,0,1,1
Q5_A4,1,"Importance: There is considerable public and scientific debate as to whether screen use helps or hinders early child development, particularly the development of language skills.","Why is this important: Many people and scientists are discussing and researching whether using screens helps or harms the development of young children, especially their language skills.",0,0,0,1
Q5_A4,2,"Objective: To examine via meta-analyses the associations between quantity (duration of screen time and background television), quality (educational programming and co-viewing), and onset of screen use and children's language skills.","Goal: The aim of this research is to look at different factors (such as how much time children spend using screens, the type of programs they watch, and whether adults watch with them) and see how they are related to children's language skills.",0,1,1,1
Q5_A4,3,"Data sources: Searches were conducted in MEDLINE, Embase, and PsycINFO in March 2019.","Where the data came from: In March 2019, searches were performed in three databases: MEDLINE, Embase, and PsycINFO.",0,0,0,1
Q5_A4,4,The search strategy included a publication date limit from 1960 through March 2019.,What the search focused on: The search for articles included publications from 1960 up until March 2019.,0,0,0,1
Q5_A4,5,Study selection: Inclusion criteria were a measure of screen use; a measure of language skills; and statistical data that could be transformed into an effect size.,"Which studies were chosen: Studies were included if they measured both screen use and language skills, and provided data that could be analyzed to determine the impact.",0,0,0,1
Q5_A4,6,Exclusion criteria were qualitative studies; child age older than 12 years; and language assessment preverbal.,"Which studies were not chosen: Studies that focused on qualitative research methods, children older than 12 years, or language assessments before children were able to speak were not included.",0,0,0,1
Q5_A4,7,"Data extraction and synthesis: The following variables were extracted: effect size, child age and sex, screen measure type, study publication year, and study design.","How the data was analyzed: The researchers collected information on several factors, including the impact size, age and gender of the children, how screen time was measured, when the study was published, and the type of study design used.",0,0,0,1
Q5_A4,8,All studies were independently coded by 2 coders and conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.,"How the studies were analyzed: Two coders individually reviewed and coded all of the studies, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.",-1,0,0,1
Q5_A4,9,"Main outcomes and measures: Based on a priori study criteria, quantity of screen use included duration of screen time and background television, quality of screen use included co-viewing and exposure to educational programs, and onset of screen use was defined as the age children first began viewing screens.","What the researchers measured: The researchers looked at how much time children spent using screens, whether adults watched with them, the type of programs they watched, and at what age they started using screens.",1,1,1,1
Q5_A4,10,The child language outcome included assessments of receptive and/or expressive language.,What the researchers measured for language skills: The researchers looked at how well children understood and/or expressed language.,-1,0,0,1
Q5_A4,11,Results: Participants totaled 18 905 from 42 studies included.,"What the results showed: The study included a total of 18,905 participants from 42 different studies.",-1,0,0,1
Q5_A4,12,Effect sizes were measured as correlations (r).,How the effect sizes were measured: The researchers used correlations (r) to measure the impact.,-1,0,0,1
Q5_A4,13,"Greater quantity of screen use (hours per use) was associated with lower language skills (screen time [n = 38; r = -0.14; 95% CI, -0.18 to -0.10]; background television [n = 5; r = -0.19; 95% CI, -0.33 to -0.05]), while better-quality screen use (educational programs [n = 13; r = 0.13; 95% CI, 0.02-0.24]; co-viewing [n = 12; r = 0.16; 95% CI, 0.07-.24]) were associated with stronger child language skills.","What the results showed: Spending more time using screens (measured in hours per use) was linked to lower language skills, while watching educational programs and watching screens with an adult were associated with stronger language skills in children.",1,1,1,1
Q5_A4,14,"Later age at screen use onset was also associated with stronger child language skills [n = 4; r = 0.17; 95% CI, 0.07-0.27].",What the results showed: Starting to use screens at a later age was linked to stronger language skills in children.,0,1,1,1
Q5_A4,15,"Conclusions and relevance: The findings of this meta-analysis support pediatric recommendations to limit children's duration of screen exposure, to select high-quality programming, and to co-view when possible.","What this means: The results of this study support the advice from pediatricians to limit the amount of time children spend using screens, choose high-quality programs, and watch screens together with an adult whenever possible.",0,0,0,1
Q6_A4,1,Animal-assisted intervention is gaining attention as a stress reduction modality.,Using animals to help reduce stress is becoming more popular.,1.0,1.0,1.0,1.0
Q6_A4,2,"Quantitative data demonstrate its effectiveness, as a recent study published in AJHPM supported that a Veterans Affairs (VA) hospital facility dog paired with a palliative care psychologist had a measurable impact on salivary cortisol levels and heart rate in hospitalized veterans.",A recent study showed that having a specially trained dog in a Veterans Affairs hospital helped to reduce stress in veterans by measuring their cortisol levels and heart rate.,1.0,1.0,1.0,1.0
Q6_A4,3,There remains an important role for qualitative insights.,Qualitative insights are still important.,1.0,0.0,1.0,1.0
Q6_A4,4,"The Denver VA palliative care team learned a range of lessons from the sudden loss of their facility dog, many of which relate directly to palliative care.",The Denver VA palliative care team learned important lessons about palliative care from the sudden loss of their facility dog.,1.0,1.0,1.0,1.0
Q6_A4,5,"The importance of communication, adjusting to changing teams, and the need for consultation and support based in shared goals and values all became evident in the course of the facility dog's illness.","During the facility dog's illness, the Denver VA palliative care team realized the importance of communication, adapting to new teams, and seeking consultation and support that align with their goals and values.",0.0,1.0,1.0,1.0
Q6_A4,6,"After her death, lessons shifted to grief and loss and how providers, patients, and a community care for each other.","After the dog died, the focus shifted to dealing with grief and loss and how healthcare providers, patients, and the community support each other.",0.0,1.0,1.0,1.0
Q6_A4,7,People's connection to the facility dog ultimately proved to be a critical factor in helping them connect with one another.,The bond between people and the facility dog ended up being an important factor in helping them connect with each other.,1.0,1.0,1.0,1.0
Q7_A3,1,Background: To examine our initial experience in carotid stenting (CS) for the prevention of stroke in patients with high-grade carotid stenoses.,Background: We wanted to see how well a procedure called carotid stenting could help prevent strokes in patients with narrow carotid arteries.,1,1,1,1
Q7_A3,2,Methods: The authors performed 26 CS procedures in 25 carotid vessels in 22 patients over a 15-month period.,Methods: We performed carotid stenting procedures on 26 carotid arteries in 22 patients over a 15-month period.,1,1,1,1
Q7_A3,3,"All carotid stenoses treated, except one, were 70% or greater.","All of the narrow carotid arteries that were treated, except for one, were at least 70% blocked.",1,1,1,1
Q7_A3,4,"Of all CS procedures, 84% were performed for obstructing atherosclerotic plaques.","Out of all the carotid stenting procedures, 84% were done to remove blockages caused by atherosclerosis (hardening of the arteries).",1,1,1,1
Q7_A3,5,"CS was performed in one patient each for carotid dissection and pseudoaneurysms caused by a gunshot wound, post-radiation stenosis, post-carotid endarterectomy (CEA) restenosis, and a flow-obstructing post-CEA intimal flap.","We performed carotid stenting in one patient each for different conditions such as carotid artery damage from a gunshot wound, narrowing after radiation treatment, and blockages after a previous carotid endarterectomy surgery.",1,1,1,1
Q7_A3,6,"Of all patients, 68.2% were symptomatic, with a history of stroke or transient ischemic attacks ipsilateral to the treated carotid artery.","Of all the patients, 68.2% had symptoms of stroke or mini-strokes on the side where the carotid artery was treated.",1,1,1,1
Q7_A3,7,"In addition, 36.4% of our patients were either hospitalized or required skilled nursing care before CS because of severe neurologic deficits.","Furthermore, 36.4% of our patients needed to be hospitalized or required skilled nursing care before carotid stenting due to severe neurological problems.",1,1,1,1
Q7_A3,8,"Using the Sundt CEA-risk classification system, 59.1% of our patients were classified as Grade III and 40.9% were Grade IV pre-CS.","Based on the Sundt classification system, 59.1% of our patients were considered to have a moderate risk for complications during carotid stenting, while 40.9% had a higher risk.",0,1,1,1
Q7_A3,9,All but one patient had either a compelling medical or anatomic reason for endovascular treatment of their carotid disease.,Almost all of the patients had a clear medical or anatomical reason for undergoing carotid stenting.,1,1,1,1
Q7_A3,10,"We used both Wallstents and Palmaz stents, and all procedures were performed via the transfemoral route.","We used two types of stents, called Wallstents and Palmaz stents, and all procedures were done by inserting them through the femoral artery in the groin.",1,1,1,1
Q7_A3,11,"Three procedures were performed in conjunction with detachable platinum coil embolization for multiple carotid pseudoaneurysms, a residual carotid ""stump"" after previous ICA thrombosis, and an ipsilateral MCA saccular aneurysm.","We also did three procedures where we used a special type of coil called a detachable platinum coil to treat multiple carotid artery pseudoaneurysms, a remnant piece of the carotid artery after a blood clot, and a bulging spot in the middle cerebral artery on the same side.",1,1,1,1
Q7_A3,12,Results: We had a 96.2% procedural technical success rate.,Results: We were successful in 96.2% of the carotid stenting procedures we performed.,1,1,1,1
Q7_A3,13,There was one death in our series 3 weeks post-CS attributable to myocardial infarction.,"Unfortunately, one patient in our study passed away from a heart attack three weeks after the carotid stenting procedure.",1,1,1,1
Q7_A3,14,"Despite a high 30-day combined death, stroke, and ipsilateral blindness rate of 27.3% (6/22 patients), only two ipsilateral strokes directly related to CS occurred (7.7% per procedures performed) from which one patient recovered fully within 5 days.","Despite a higher rate of complications within 30 days after the carotid stenting procedure (27.3% in 6 out of 22 patients), there were only two strokes that were directly caused by the procedure (7.7% per procedure). Fortunately, one of the patients fully recovered within 5 days.",1,1,1,1
Q7_A3,15,"The average follow-up post-CS was 5.9 months (range, 3 weeks-15 months).","On average, we followed up with patients for about 5.9 months after the carotid stenting procedure, but some patients were followed for as little as 3 weeks or as long as 15 months.",1,1,1,1
Q7_A3,16,"Of successfully treated vessels, 58.3% have undergone 6-month follow-up vascular imaging, which has revealed a 14.3% rate of occlusion or restenosis greater than 50%.","Out of the carotid arteries that were successfully treated, 58.3% had follow-up imaging after 6 months. In these cases, we found that 14.3% of the arteries were either completely blocked or narrowed again by more than 50%.",1,1,1,1
Q7_A3,17,"At or beyond 1 month post-CS, 19 of 21 surviving patients (90.5%) were ambulatory, fluent of speech, and independent, and none has thus far suffered a delayed stroke or TIA.","After at least 1 month following the carotid stenting procedure, 90.5% of the patients were able to walk, speak fluently, and live independently. So far, none of them have experienced a stroke or mini-stroke after the procedure.",1,1,1,1
Q7_A3,18,Conclusion: CS seems to be a reasonable alternative to medical management for the treatment of carotid disease in patients deemed to be poor candidates for standard carotid surgery.,Conclusion: Carotid stenting appears to be a good option for treating carotid disease in patients who are not suitable candidates for regular carotid surgery.,1,1,1,1
Q7_A3,19,Longer term follow-up is necessary to assess the durability of carotid revascularization using CS.,We need to continue tracking patients over a longer period of time to see how effective carotid stenting is for keeping the carotid arteries open.,1,1,1,1
Q8_A1,1,"The frequency and severity of 17 side effects presumably associated with stimulant medication were assessed during a rigorous, triple-blind, placebo-controlled, crossover evaluation of methylphenidate, 0.3 and 0.5 mg/kg twice a day, in 83 children with attention deficit hyperactivity disorder.","We wanted to find out how often and how severe certain side effects were in children with attention deficit hyperactivity disorder who took a medication called methylphenidate. We did a very detailed and careful study where neither the researchers nor the children knew who was taking the medicine or a fake pill. We tested two different doses of the medicine, 0.3 mg/kg and 0.5 mg/kg, given twice a day. In total, 83 children took part in the study.",1.0,1.0,1.0,1.0
Q8_A1,2,Side effects were rated by parents and teachers at the end of each weekly drug condition.,"At the end of each week, parents and teachers were asked to rate the side effects the children experienced during that week.",1.0,1.0,1.0,1.0
Q8_A1,3,Three children (3.6%) had side effects that were sufficiently serious to warrant immediate discontinuation of medication.,Three children (3.6%) had side effects that were serious enough to stop taking the medication right away.,1.0,1.0,1.0,1.0
Q8_A1,4,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","According to the ratings from parents, the side effects of decreased appetite, insomnia, stomachaches, and headaches were more common and more severe when the children took the medication compared to when they took a fake pill.",0.0,1.0,1.0,1.0
Q8_A1,5,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Less than half of the children had these side effects, and even for those who did, they were not very severe.",1.0,1.0,1.0,1.0
Q8_A1,6,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Teachers didn't notice much difference in the children's behavior during the different drug conditions, except that they rated the children as staring, sad, and anxious less often as the medication dose increased.",0.0,1.0,1.0,1.0
Q8_A1,7,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","According to what parents said, only the side effects of decreased appetite, trouble sleeping, stomachaches, and headaches happened more often and were more severe when the children took the medicine compared to when they took a fake pill.",-1.0,1.0,1.0,1.0
Q8_A1,8,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Less than half of the children had these side effects, and for those who did, they were not very severe.",0.0,1.0,1.0,1.0
Q8_A1,9,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Teachers didn't notice much difference in the children's behavior during the different drug conditions, except that they rated the children as staring, sad, and anxious less often as the medication dose increased.",0.0,1.0,1.0,1.0
Q8_A1,10,"Surprisingly, a high frequency of these behavior side effects were reported during the placebo condition.","Surprisingly, many of these behavior side effects were reported even when the children were taking a fake pill.",1.0,1.0,1.0,1.0
Q8_A1,11,"Stimulant medication within this therapeutic range, therefore, results in few, generally mild side effects.",Taking stimulant medication within the recommended range usually only causes a few mild side effects.,1.0,1.0,1.0,1.0
Q9_A8,1,Background and objectives: Probiotics have been widely used for host immune system enhancement but with limited knowledge regarding the immunomodulation mechanisms by which they assist the mucosal innate immune response.,"Background: Probiotics are commonly used to boost our immune system, but we don't know much about how they actually help our body's defense mechanisms. Objective: The aim of this study is to understand how probiotics assist the natural defense system in our bodies.",0,1,1,1
Q9_A8,2,"We investigated the effects of probiotics on the modulation of the innate mucosal immune response particularly in association with Toll-like receptor (TLR)-2, TLR-4 and nuclear factor-kappa B (NF-κB) p65 and p105.","We studied how probiotics affect the natural defense system in our body, specifically focusing on Toll-like receptors and nuclear factor-kappa B.",0,0,1,1
Q9_A8,3,Materials and methods: We randomized 24 male BALB/c mice into four groups.,Methods: We divided 24 male BALB/c mice into four groups by chance.,0,0,0,1
Q9_A8,4,Two groups were administered probiotics for 21 consecutive days; one of these groups was challenged with Lipopolysaccharide (LPS) on day 15.,"Two groups of mice were given probiotics every day for three weeks. On day 15, one of these groups was also given Lipopolysaccharide (LPS).",0,0,0,1
Q9_A8,5,The third group was challenged with only LPS.,The third group was only given Lipopolysaccharide (LPS).,1,1,1,1
Q9_A8,6,The fourth group remained untreated.,The fourth group did not receive any treatment.,1,1,1,1
Q9_A8,7,All mice were sacrificed after 21 days.,All mice were euthanized after 21 days.,0,1,0,1
Q9_A8,8,"An immunohistochemistry procedure on the ileum was performed and monoclonal antibodies specific for TLR-2, TLR-4 and NF-κB p65 and p105 were used for the analysis of innate lymphoid cells.","We performed a procedure on the small intestine called immunohistochemistry. We used special antibodies to analyze certain cells involved in our natural defense system, specifically TLR-2, TLR-4, and NF-κB p65 and p105.",0,0,0,1
Q9_A8,9,"Results: In the LPS-only treated group, there was a significant decrease in p105, indicating an alternative transcription pathway for the process of pro-inflammatory cytokine production.","Results: When we only gave the mice Lipopolysaccharide (LPS), we saw a significant decrease in p105, which suggests a different way that pro-inflammatory cytokines are produced.",0,0,1,1
Q9_A8,10,In the probiotics-only treated group there was significant enhancement of TLR-2 and TLR-4 and NF-κB p65 and p105.,"Results: In the group that only received probiotics, we saw a significant increase in TLR-2, TLR-4, and NF-κB p65 and p105.",0,0,0,1
Q9_A8,11,"When mice treated with probiotics were exposed to LPS, there was a significant decrease in NF-κB p65 and p105, indicating employment of the classical pathway for pro-inflammatory cytokine production.","Results: When we gave the mice probiotics and also exposed them to Lipopolysaccharide (LPS), we saw a significant decrease in NF-κB p65 and p105. This suggests that a different pathway was used to produce pro-inflammatory cytokines in this case.",1,0,-1,1
Q9_A8,12,Conclusion: Probiotics can enhance the innate mucosal immune response in healthy mice and can maintain the homeostasis of the gut mucosal immune response against LPS through the activation of the classical NF-κB pathway.,Conclusion: Probiotics can boost the natural defense system in healthy mice and help maintain a balanced immune response in the gut by activating a specific pathway.,1,1,1,1
Q10_A9,1,"Objective: Does short-term cryotherapy improve pain, function and quality of life in people with knee osteoarthritis (OA)?","Can using cryotherapy for a short period of time help reduce pain, improve function, and enhance quality of life for people with knee osteoarthritis?",1,0,1,1
Q10_A9,2,"Design: Randomised controlled trial with concealed allocation, blinded assessment of some outcomes, and intention-to-treat analysis.","We conducted a study where participants were randomly assigned to different groups, and some of the assessments were done without the participants or the assessors knowing which group they were in. We also analyzed the results based on the intention to treat, meaning we considered all participants regardless of whether they completed the study or not.",1,1,1,1
Q10_A9,3,Participants: People living in the community with knee OA.,We recruited individuals from the community who have knee osteoarthritis.,1,0,1,1
Q10_A9,4,"Interventions: The experimental group received cryotherapy, delivered as packs of crushed ice applied to the knee with mild compression.","The experimental group in our study received cryotherapy, which involved applying crushed ice packs to their knees with gentle pressure.",0,1,1,1
Q10_A9,5,The control group received the same regimen but with sham packs filled with sand.,"The control group in our study received a similar treatment, but instead of real ice packs, they were given packs filled with sand that didn't have any therapeutic effect.",0,1,1,1
Q10_A9,6,The interventions were applied once a day for 4 consecutive days.,The interventions were applied once a day for 4 days in a row.,1,0,1,1
Q10_A9,7,Outcome measures: Participants were assessed at baseline and on the day after the 4-day intervention period.,We assessed participants before the study began and the day after they completed the 4-day treatment period.,1,1,1,1
Q10_A9,8,The primary outcome was pain intensity according to a visual analogue scale.,"The main thing we were looking at was how much pain the participants were feeling, and we used a scale to measure it.",0,1,1,1
Q10_A9,9,"Secondary outcomes were baseline to post-intervention changes according to the Western Ontario and McMaster Universities Osteoarthritis, Knee injury and Osteoarthritis Outcome; Timed Up and Go test; and 30-Second Chair to Stand test.","Other things we were interested in were changes in function and mobility. We used different tests, including the Western Ontario and McMaster Universities Osteoarthritis questionnaire, the Timed Up and Go test, and the 30-Second Chair to Stand test to measure these changes.",0,0,1,1
Q10_A9,10,Results: Sixty participants were randomised into the experimental group (n = 30) or the control group (n = 30).,"We had 60 participants in our study, with 30 people in the group that received cryotherapy and 30 people in the control group.",0,1,1,1
Q10_A9,11,Twenty-nine participants from each group completed the trial.,A total of 29 participants from each group completed the study.,1,1,1,1
Q10_A9,12,"The mean between-group difference in change in pain severity was -0.8 cm (95% CI -1.6 to 0.1), where negative values favour the experimental group.","On average, the group that received cryotherapy had a change in pain severity that was 0.8 centimeters lower compared to the control group, but the difference could be as much as 1.6 centimeters lower or 0.1 centimeters higher. In other words, the cryotherapy group had less pain than the control group.",0,0,1,1
Q10_A9,13,This result did not reach the nominated smallest worthwhile effect of 1.75 cm.,The difference in pain severity between the two groups did not meet the threshold of at least a 1.75 centimeter improvement that we had set.,1,1,1,1
Q10_A9,14,"The secondary outcomes had less-precise estimates, with confidence intervals that spanned worthwhile, trivial and mildly harmful effects.","The secondary outcomes were not as clear-cut, and the confidence intervals showed that the effects could range from being beneficial to having no effect or even slightly harmful.",0,1,1,1
Q10_A9,15,Conclusion: Short-term cryotherapy was not superior to a sham intervention in terms of relieving pain or improving function and quality of life in people with knee OA.,"In conclusion, using cryotherapy for a short period of time did not show better results than a sham treatment in terms of reducing pain or improving function and quality of life for individuals with knee osteoarthritis.",0,0,1,1
Q10_A9,16,"Although cryotherapy is considered to be a widely used resource in clinical practice, this study does not suggest that it has an important short-term effect, when compared with a sham control, as a non-pharmacological treatment for people with knee osteoarthritis.","Even though cryotherapy is commonly used in clinics, this study found that it does not have a significant short-term effect compared to a sham treatment for individuals with knee osteoarthritis.",0,0,1,1
Q11_A1,1,The evidence of long-term clinical dynamic on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case are less.,We don't have much evidence about the long-term effects of individuals testing positive for SARS-CoV-2 RNA again after recovering from the virus.,1.0,1.0,1.0,1.0
Q11_A1,2,"We performed a 108 days follow-up on dynamic clinical presentations in a case, who hospitalized three times due to the positive recurrence of SARS-CoV-2 RNA after discharge, to understand the prognosis of the 2019-Coronavirus disease (COVID-19).","We followed a patient for 108 days to see what happened after they tested positive for SARS-CoV-2 RNA again, even after being discharged from the hospital multiple times. We wanted to see what the outlook was for COVID-19 in this case.",1.0,1.0,1.0,1.0
Q11_A1,3,"In this case, positive SARS-CoV-2 recurred even after apparent recovery (normal CT imaging, no clinical symptoms, negative SARS-CoV-2 on stool sample and negative serum IgM test) from COVID-19, viral shedding duration lasted for 65 days, the time from symptom onset to disappearance was up to 95 days.","In this case, the person tested positive for SARS-CoV-2 even after seeming to recover from COVID-19. They had normal CT scans, no symptoms, and negative tests on stool and serum samples. The virus was still detectable for 65 days, and it took 95 days from when symptoms started for them to fully recover.",1.0,1.0,1.0,1.0
Q11_A1,4,"Erythrocyte-associated indicators, liver function and serum lipid metabolism presented abnormal throughout during the observation period.","The patient had abnormal levels in their red blood cell-associated indicators, liver function, and serum lipid metabolism throughout the entire observation period.",1.0,1.0,1.0,1.0
Q11_A1,5,Awareness of atypical presentations such as this one is important to prompt the improvement of the management of COVID-19.,It's important to be aware of unusual symptoms like these in order to improve the treatment of COVID-19.,1.0,1.0,1.0,1.0
Q12_A2,1,"The use of oral terbinafine in the treatment of superficial dermatophyte infections has been extensively studied, using different treatment regimens.","Researchers have done a lot of studies on how well oral terbinafine works for treating certain types of skin infections caused by a fungus, and they have tried out different ways of giving the medicine.",0.0,0.0,1.0,1.0
Q12_A2,2,"To evaluate the efficacy of short-term therapy with oral terbinafine in cases of tinea cruris/corporis, 22 patients (21 male and one female) with mycologically proven tinea cruris/corporis, were included in the present study.","In this study, researchers wanted to see how well oral terbinafine worked for treating a certain type of skin infection called tinea cruris/corporis. They included 22 patients, the majority of whom were male, who had been diagnosed with this infection.",1.0,0.0,1.0,1.0
Q12_A2,3,Each patient received one tablet of terbinafine 250 mg daily for 1 week.,"Each patient took one terbinafine tablet, containing 250 mg of the medicine, every day for a week.",1.0,1.0,1.0,1.0
Q12_A2,4,Patients were followed-up for 6 weeks after completion of treatment.,The patients were checked on for 6 weeks after they finished taking the medicine.,1.0,1.0,1.0,1.0
Q12_A2,5,"Clinical and mycological assessments were performed at the end of treatment, and at the end of the follow-up period.","The doctors looked at the patients' symptoms and did tests to see if the fungus was still present, both right after they finished taking the medicine and after the 6-week follow-up period.",0.0,1.0,1.0,1.0
Q12_A2,6,"The mean sum of scores of signs and symptoms in all patients decreased significantly from 12.36 before treatment to 0 at the end of the follow-up period, and mycological investigations were negative in all patients at the end of the follow-up period.","On average, the patients had significant improvement in their symptoms, going from a score of 12.36 before treatment to no symptoms at all after 6 weeks. Tests also showed that the fungus was gone in all patients after the 6-week period.",1.0,1.0,1.0,1.0
Q12_A2,7,Our results show that 1-week therapy with oral terbinafine is highly effective in the treatment of tinea cruris/corporis.,"Based on our findings, taking oral terbinafine for just one week is a very effective treatment for tinea cruris/corporis.",1.0,1.0,1.0,1.0
Q13_A7,1,Abdominal aortic aneurysm (AAA) is defined as a permanent dilatation of the abdominal aorta that exceeds 3 cm.,Abdominal aortic aneurysm (AAA) is when the main blood vessel in your abdomen gets enlarged and stretches out more than 3 cm.,1.0,1.0,1.0,1.0
Q13_A7,2,Most AAAs arise in the portion of abdominal aorta distal to the renal arteries and are defined as infrarenal.,"Most AAAs occur in the lower part of the abdominal aorta, below the renal arteries.",1.0,1.0,1.0,1.0
Q13_A7,3,Most AAAs are totally asymptomatic until catastrophic rupture.,Most AAAs do not show any symptoms until they rupture suddenly and cause serious problems.,1.0,1.0,1.0,1.0
Q13_A7,4,The strongest predictor of AAA rupture is the diameter.,The size of the AAA is the best indicator of whether it is at risk of rupturing.,1.0,1.0,1.0,1.0
Q13_A7,5,Surgery is indicated to prevent rupture when the risk of rupture exceeds the risk of surgery.,Surgery is recommended to prevent rupture when the risk of rupture is higher than the risk of the surgery itself.,1.0,1.0,1.0,1.0
Q13_A7,6,"In this review, we aim to analyze this disease comprehensively, starting from an epidemiological perspective, exploring etiology and pathophysiology, and concluding with surgical controversies.","In this review, we will take a thorough look at this disease, beginning with its prevalence in the population and causes, studying how it affects the body and ending with a discussion on different opinions about the best surgical approach.",0.0,1.0,1.0,1.0
Q13_A7,7,We will pursue these goals by addressing eight specific questions regarding AAA: (1) Is the incidence of AAA increasing? (2) Are ultrasound screening programs for AAA effective? (3) What causes AAA: Genes versus environment? (4) Animal models: Are they really relevant? (5) What pathophysiology leads to AAA? (6) Indications for AAA surgery: Are surgeons over-eager to operate? (7) Elective AAA repair: Open or endovascular? (8) Emergency AAA repair: Open or endovascular?,"To understand AAA better, we will answer eight important questions: (1) Is the number of people with AAA increasing? (2) Do ultrasound screenings for AAA work? (3) Is AAA caused by genes or the environment? (4) Are animal models useful for studying AAA? (5) What happens in the body that leads to AAA? (6) Do surgeons rush into surgery for AAA? (7) Is open surgery or a less invasive approach better for planned AAA repair? (8) Is open surgery or a less invasive approach better for emergency AAA repair?",1.0,1.0,1.0,1.0
Q14_A1,1,"Idiopathic pulmonary fibrosis (IPF) is an incurable condition that is characterized by progressive pulmonary fibrosis, architectural distortion of the lung and loss of gas exchange units.","Idiopathic pulmonary fibrosis (IPF) is a medical condition that cannot be cured. It causes the lungs to become scarred and lose their normal structure, making it harder for them to exchange oxygen and carbon dioxide.",1.0,1.0,1.0,1.0
Q14_A1,2,"Until recently, there was no effective treatment for this condition.","Until recently, there was no way to effectively treat this condition.",1.0,1.0,1.0,1.0
Q14_A1,3,"However, there were two landmark trials published earlier this year, which have changed the management of this condition.","However, earlier this year, two important studies were published that have changed how this condition is treated.",1.0,1.0,1.0,1.0
Q14_A1,4,Pirfenidone (Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis trial) and nintedanib (Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis-1 and -2 trials) have both demonstrated positive outcomes in patients with IPF.,Pirfenidone (Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis trial) and nintedanib (Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis-1 and -2 trials) have both shown positive results in patients with IPF.,-1.0,0.0,1.0,1.0
Q14_A1,5,"In this perspective, we critically discuss the role of these agents in IPF and in the broader pulmonary fibrosis population.","In this article, we will carefully examine how these drugs can be used to treat IPF and other conditions causing pulmonary fibrosis.",1.0,0.0,1.0,1.0
Q15_A1,1,"Objectives: We compared the semiquantitative measurement of acetoacetate using urinary dipsticks with the bedside quantitative fingerprick measurement of the principal ketone bodies 3-beta-hydroxybutyrate, for the diagnosis of ketoacidosis.","Our goal was to compare two different methods for diagnosing ketoacidosis – one using urine dipsticks to measure acetoacetate levels, and another using a fingerprick test to measure the levels of 3-beta-hydroxybutyrate, a key substance in ketone bodies.",0,0,1,1
Q15_A1,2,Methods: This is a one year retrospective study of patients who presented with hyperglycemia levels of 250 mg/l or greater in the Emergency Department setting.,We conducted a study looking back at medical records for patients who came to the emergency department with high blood sugar levels (250 mg/l or higher) over the course of a year.,1,1,1,1
Q15_A1,3,"We compared the sensitivity, specificity, and predictive value of ketonuria and ketonemia for the diagnosis of ketoacidosis (urine or blood ketone bodies, blood bicarbonates <20 mmol/l, anion gap >16 meq/l) in a sample of patients for whom the levels of ketone bodies in the blood and urine as well as serum electrolytes were available.","We looked at how well urine and blood tests for ketone bodies can diagnose ketoacidosis in patients. We compared the results with other measures, such as blood bicarbonates and anion gap, and looked at the accuracy, reliability and predictability of these tests.",1,1,1,1
Q15_A1,4,Results: We studied 355 hyperglycemic patients.,We looked at medical records for 355 patients with high blood sugar levels.,1,1,1,1
Q15_A1,5,"The median time between arrival and dipstick testing was 21 min, and was greater than 2 h in more than 10% of cases.","On average, it took 21 minutes for urine dipstick tests to be done after patients arrived in the emergency department. However, in over 10% of cases, it took more than 2 hours.",0,0,1,1
Q15_A1,6,Comparison between ketonuria and ketonemia was performed in 173 patients (6% with diabetic ketoacidosis).,"We compared urine and blood tests for ketone bodies in 173 patients, 6% of whom had diabetic ketoacidosis.",0,0,1,1
Q15_A1,7,Ketonuria equal to or less than one cross or a 3-beta-hydroxybutyrate value lower than 3 mmol/l enabled ketoacidosis to be excluded (negative predictive value 100%).,"If a urine test showed a reading of one cross or less, or if a fingerprick test showed a 3-beta-hydroxybutyrate level lower than 3 mmol/l, it meant that ketoacidosis could be ruled out with 100% certainty.",0,0,1,1
Q15_A1,8,"At two-cross cutoff points for ketonuria and at the 3 mmol/l cutoff point for ketonemia, the two tests had the same sensitivity (100%), but the specificity of 3-beta-hydroxybutyrate (94%) was significantly higher (P<0.0001) than that of ketonuria (77%).","When we set a cutoff point of two crosses for ketonuria and 3 mmol/l for ketonemia, we found that both tests were equally sensitive in detecting ketoacidosis (100%). However, the fingerprick test measuring 3-beta-hydroxybutyrate had a higher specificity (94%) compared to the urine test for ketonuria (77%), meaning it was more accurate in correctly identifying cases of ketoacidosis.",0,0,1,1
Q15_A1,9,The best positive predictive value for ketonemia was obtained at the 5 mmol/l cutoff point (100%) and for ketonuria at the three-cross cutoff point (26%).,"The fingerprick test measuring 3-beta-hydroxybutyrate had a positive predictive value of 100% when the cutoff point was set at 5 mmol/l, meaning it was highly accurate in correctly identifying cases of ketoacidosis. On the other hand, the urine test for ketonuria had a positive predictive value of only 26% when the cutoff point was set at three crosses, indicating that it was not as reliable in predicting ketoacidosis.",0,0,1,1
Q15_A1,10,"At the three-cross cutoff point for ketonuria and at the 5 mmol/l cutoff point for ketonemia, the two tests had the same negative likelihood ratio (0.1), but the positive likelihood ratio of 3-beta-hydroxybutyrate (infinite) was higher than that of ketonuria.","When we set a cutoff point of three crosses for ketonuria and 5 mmol/l for ketonemia, both tests had the same ability to rule out ketoacidosis (negative likelihood ratio of 0.1). However, the fingerprick test measuring 3-beta-hydroxybutyrate had a higher ability to confirm ketoacidosis (positive likelihood ratio of infinite) compared to the urine test for ketonuria.",1,1,1,1
Q15_A1,11,Conclusion: The measurement of 3-beta-hydroxybutyrate in capillary blood is faster and more effective than the use of dipsticks in the urine to detect ketoacidosis in the Emergency Department setting.,"In conclusion, using a fingerprick test to measure 3-beta-hydroxybutyrate levels in the blood is a faster and more effective way to diagnose ketoacidosis in the emergency department compared to using urine dipsticks.",1,1,1,1
Q16_A2,1,Factors other than the glomerular filtration rate (GFR) can affect creatinine clearance (Ccr) and serum creatinine concentration (Pcr).,Other factors besides the rate at which your kidneys filter your blood can impact your body's ability to get rid of creatinine and the amount of creatinine in your blood.,1,1,1,1
Q16_A2,2,The effect of dietary protein and antihypertensive therapy on Ccr the reciprocal of the Pcr (1/Pcr).,Eating high levels of protein and taking certain medications to control blood pressure can affect how your body gets rid of creatinine and the levels of creatinine in your blood.,1,1,1,1
Q16_A2,3,"and their determinants (GFR, creatinine clearance from tubular secretion (CTScr), and creatinine excretion (UcrV) values) was assessed in patients participating in the Modification of Diet in Renal Disease (MDRD) Study.","The effect of certain factors on how your body gets rid of creatinine and the levels of creatinine in your urine was studied in patients involved in the Modification of Diet in Renal Disease (MDRD) Study. These factors include the rate at which your kidneys filter your blood, the clearance of creatinine through tubular secretion, and the amount of creatinine you excrete.",1,1,1,1
Q16_A2,4,This study compared the effects of assignment to a low versus usual-protein diet and to a low versus usual-blood pressure goal on the decline in these measurements over 3 yr in 585 patients with baseline GFR of 25 to 55 mL/min per 1.73 m2 (Study A).,"In this study, researchers looked at how following a low-protein diet or trying to achieve a lower blood pressure goal affected the decline of certain measurements in 585 patients with reduced kidney function. They studied these patients over a period of 3 years.",1,1,1,1
Q16_A2,5,"This study also assessed correlations and associations of these measurements with each other and with protein intake, blood pressure, class of antihypertensive agents, and renal diagnosis in 840 patients with baseline GFR of 13 to 55 mL/min per 1.73 m2 (Studies A and B).","In addition to the previous study, this research also looked at how these measurements were related to each other and to factors such as protein intake, blood pressure, type of blood pressure medication, and kidney diagnosis. They studied 840 patients with reduced kidney function over a range of GFR levels.",1,1,1,1
Q16_A2,6,"In Study A, the estimated mean decline in GFR at 3 yr did not differ significantly between the low and usual-protein diet groups (-10.9 versus -12.1 mL/min).","In the first study, there was no significant difference in the average decline in kidney function after 3 years between the group that followed a low-protein diet and the group that followed a usual-protein diet. The average decline was about 10.9 to 12.1 mL/min.",0,1,1,1
Q16_A2,7,"In contrast, CTScr declined more in the low-protein diet group (-7.8 versus -3.6 mL/min, P < .05).","However, the decline in creatinine clearance through tubular secretion was greater in the low-protein diet group compared to the usual-protein diet group. The decline was about 7.8 mL/min compared to 3.6 mL/min and was statistically significant.",1,0,1,1
Q16_A2,8,"Consequently, the low-protein diet group had a greater decline in Ccr (-17.6 versus -14.4 mL/min, P < .05).","As a result, the group that followed a low-protein diet had a greater decline in the body's ability to get rid of creatinine compared to the group that followed a usual-protein diet. The decline was about 17.6 mL/min compared to 14.4 mL/min and was statistically significant.",0,1,1,1
Q16_A2,9,"The low-protein diet group also had a greater decline in UcrV (-306 versus -92 mg/day, P < .05).","Additionally, the group that followed a low-protein diet had a greater decline in the amount of creatinine excreted in their urine compared to the group that followed a usual-protein diet. The decline was about 306 mg/day compared to 92 mg/day and was statistically significant.",0,1,1,1
Q16_A2,10,"The decline in UcrV was proportionately greater than the decline in CTScr hence the decline in 1/Pcr was less in the low-protein diet group (-0.091 versus -0.122 dl/mg, P < .05).",The decrease in the amount of creatinine excreted in urine was larger compared to the decrease in creatinine clearance through tubular secretion in the group that followed a low-protein diet. This resulted in a smaller decrease in the reciprocal of the creatinine concentration in the blood in the low-protein diet group. The decrease was about 0.091 dl/mg compared to 0.122 dl/mg and was statistically significant.,0,1,1,1
Q16_A2,11,"Similarly, in Study A, there was no significant difference in the decline in GFR at 3 yr between the low and usual-blood pressure groups (-10.7 versus -12.3 mL/ min).","Similarly, in the first study, there was no significant difference in the decrease in kidney function after 3 years between the group that aimed for a lower blood pressure and the group that aimed for a usual blood pressure. The decrease was about 10.7 to 12.3 mL/min.",0,1,1,1
Q16_A2,12,"However, there was a lesser decline in CTScr in the low blood pressure group (-4.7 versus -6.7 mL/ min, P < .05).","However, the decline in creatinine clearance through tubular secretion was smaller in the group that aimed for a lower blood pressure compared to the group that aimed for a usual blood pressure. The decline was about 4.7 mL/min compared to 6.7 mL/min and was statistically significant.",0,1,1,1
Q16_A2,13,"Consequently, the decline in Ccr was less in the low blood pressure group (-14.2 versus -17.8 mL/min, P < .05).","As a result, the group that aimed for a lower blood pressure had a smaller decline in the body's ability to get rid of creatinine compared to the group that aimed for a usual blood pressure. The decline was about 14.2 mL/min compared to 17.8 mL/min and was statistically significant.",0,1,1,1
Q16_A2,14,There was no significant difference in UcrV between the blood pressure groups (-192 versus -205 mg/day).,There was no significant difference in the amount of creatinine excreted in urine between the group that aimed for a lower blood pressure and the group that aimed for a usual blood pressure. The amounts were about 192 mg/day and 205 mg/day.,0,1,1,1
Q16_A2,15,"Hence, the decline in 1/Pcr paralleled the decline in Ccr; it was less in the low blood pressure group (-0.091 versus -0.122 dL/mg, P < .05).","Therefore, the decrease in the reciprocal of the creatinine concentration in the blood mirrored the decrease in the body's ability to get rid of creatinine. It was smaller in the group that aimed for a lower blood pressure compared to the group that aimed for a usual blood pressure. The decrease was about 0.091 dL/mg compared to 0.122 dL/mg and was statistically significant.",1,1,1,1
Q16_A2,16,"In Studies A and B, correlations of rates of decline in Ccr and GFR were 0.64 and 0.79, respectively (P < 0.001).","In both studies, there was a strong correlation between the rates of decline in the body's ability to get rid of creatinine and the decline in kidney function. This means that as the body's ability to get rid of creatinine decreased, kidney function also decreased. The correlation was 0.64 and 0.79, respectively, which means it was statistically significant.",1,1,1,1
Q16_A2,17,"Correlations of rates of decline in 1/Pcr and GFR were 0.79 and 0.85, respectively (P < 0.001).","Similarly, there was a strong correlation between the decrease in the reciprocal of the creatinine concentration in the blood and the decline in kidney function. As the reciprocal of the creatinine concentration decreased, kidney function also decreased. The correlation was 0.79 and 0.85, respectively, which means it was statistically significant.",1,1,1,1
Q16_A2,18,"In Studies A and B combined, baseline GFR, CTScr and UcrV correlated significantly with protein intake (r = 0.45, 0.47, and 0.36, respectively; P < 0.001), but not with blood pressure.","In both studies combined, the initial level of kidney function, creatinine clearance through tubular secretion, and the amount of creatinine excreted in urine were significantly correlated with protein intake. However, they were not correlated with blood pressure. This means that higher protein intake was associated with better initial kidney function, higher clearance of creatinine, and higher amount of creatinine excreted in urine.",1,1,1,1
Q16_A2,19,"Baseline CTScr was significantly lower in patients with polycystic kidney disease and tubulointerstitial diseases or urinary tract diseases, compared with glomerular and other diseases (P < 0.05).","At the start of the study, patients with polycystic kidney disease and certain urinary tract diseases had a lower rate of creatinine clearance through tubular secretion compared to patients with other kidney diseases. The difference was statistically significant.",0,0,1,1
Q16_A2,20,"It was also lower in patients who were taking calcium channel blockers, compared with patients not taking these agents, and in patients not taking diuretics, compared with patients taking diuretics (P < 0.05).","Patients who were taking calcium channel blockers had a lower rate of creatinine clearance through tubular secretion compared to patients who were not taking these medications. Similarly, patients who were not taking diuretics had a lower rate of creatinine clearance compared to patients who were taking diuretics. These differences were statistically significant.",1,0,1,1
Q16_A2,21,These results show that creatinine secretion and excretion are affected by protein intake.,These findings demonstrate that the body's ability to get rid of creatinine is influenced by the amount of protein you consume.,1,1,1,1
Q16_A2,22,Creatinine secretion is also affected by antihypertensive therapy and renal diagnosis.,Treating high blood pressure and the specific diagnosis of kidney disease can also impact how creatinine is secreted in the body.,1,1,1,1
Q16_A2,23,"In the MDRD Study, the low-protein diet reduced creatinine secretion and excretion, and the low blood pressure goal slowed the decline in creatinine secretion.","In the MDRD Study, following a low-protein diet decreased the amount of creatinine secreted and excreted by the body, and aiming for a lower blood pressure goal slowed down the decrease in creatinine secretion.",1,1,1,1
Q16_A2,24,These effects caused differences between the diet groups and between the blood pressure groups in Ccr and 1/Pcr that were not the result of differences in GFR.,"These effects led to differences in creatinine clearance and the reciprocal of creatinine concentration in the blood between the diet groups and the blood pressure groups, which were not due to differences in the rate at which the kidneys filtered the blood.",-1,0,1,1
Q16_A2,25,Studies assessing the effects of these interventions on the progression of renal disease should measure GFR in addition to Ccr and Pcr.,"When studying the effects of these interventions on the progression of kidney disease, it's important to measure not only the rate at which the kidneys filter the blood, but also the body's ability to get rid of creatinine and the levels of creatinine in the blood.",1,1,1,1
Q17_A4,1,The realization that low-glycemic index diets were formulated using resistant starch led to more than a decade of research on the health effects of resistant starch.,Scientists have been studying resistant starch for over a decade to understand how it affects our health. This research was sparked by the discovery that low-glycemic index diets are based on resistant starch.,1.0,0.0,1.0,1.0
Q17_A4,2,Determination of the metabolizable energy of the resistant starch product allowed for the performance of isocaloric studies.,"By figuring out how much energy resistant starch provides when metabolized, researchers were able to conduct studies that compared it to other sources of the same amount of calories.",1.0,1.0,1.0,1.0
Q17_A4,3,"Fermentation of resistant starch in rodent studies results in what appears to be a healthier gut, demonstrated by increased amounts of short-chain fatty acids, an apparent positive change in the microbiota, and increased gene expression for gene products involved in normal healthy proliferation and apoptosis of potential cancer cells.","When resistant starch is broken down in the gut of rodents, it seems to improve their gut health. This is shown by an increase in short-chain fatty acids, changes in the gut bacteria, and increased expression of genes that help prevent the growth of cancer cells.",1.0,0.0,1.0,1.0
Q17_A4,4,"Additionally, consumption of resistant starch was associated with reduced abdominal fat and improved insulin sensitivity.",Eating resistant starch can help reduce belly fat and improve how our bodies respond to insulin.,1.0,1.0,1.0,1.0
Q17_A4,5,Increased serum glucagon-like peptide 1 (GLP-1) likely plays a role in promoting these health benefits.,The health benefits of resistant starch are likely due to an increase in a hormone called glucagon-like peptide 1 (GLP-1).,1.0,1.0,0.0,1.0
Q17_A4,6,One rodent study that did not use isocaloric diets demonstrated that the use of resistant starch at 8% of the weight of the diet reduced body fat.,"In a study with rodents, adding resistant starch to their diet reduced their body fat even when their calorie intake was not controlled.",0.0,1.0,0.0,1.0
Q17_A4,7,This appears to be approximately equivalent to the human fiber requirement.,This is about the same amount of resistant starch that humans need to meet their fiber requirement.,1.0,1.0,1.0,1.0
Q17_A4,8,"In human subjects, insulin sensitivity is increased with the feeding of resistant starch.",Feeding humans resistant starch can improve their insulin sensitivity.,1.0,0.0,1.0,1.0
Q17_A4,9,"However, only 1 of several studies reports an increase in serum GLP-1 associated with resistant starch added to the diet.","However, only one out of many studies found that adding resistant starch to the diet increased the levels of GLP-1 hormone in the blood.",1.0,1.0,1.0,1.0
Q17_A4,10,"This means that other mechanisms, such as increased intestinal gluconeogenesis or increased adiponectin, may be involved in the promotion of improved insulin sensitivity.","This suggests that there may be other ways that resistant starch improves insulin sensitivity, such as increasing the production of glucose in the intestines or increasing the levels of a protein called adiponectin.",1.0,1.0,0.0,1.0
Q17_A4,11,Future research may confirm that there will be improved health if human individuals consume the requirement for dietary fiber and a large amount of the fiber is fermentable.,"Further research is needed to determine if consuming enough fermentable fiber, which includes resistant starch, as part of a high-fiber diet can lead to better overall health.",1.0,1.0,1.0,1.0
Q18_A2,1,Background: The current experiment investigated the impact of two potential confounding variables on the postural balance in young participants: the induced-experimental activity prior to the static postural measurements and the well-documented time-of-day effects.,"Background: In this study, we looked at how two factors might affect a person's balance: the activity they did before being tested, and the time of day.",1.0,1.0,1.0,1.0
Q18_A2,2,We mainly hypothesized that an exhaustive exercise and a high attention-demanding task should result in alterations of postural control.,We predicted that doing a strenuous exercise or a mentally demanding task would change a person's ability to maintain balance.,1.0,1.0,1.0,1.0
Q18_A2,3,"Methods: Ten participants performed three experimental sessions (differentiated by the activity - none, cognitive or physical - prior of the assessment of postural stability), separated by one day at least.","Methods: We had ten participants come in for three different sessions, with each session spaced at least a day apart. In each session, the participants either didn't do any activity, did a mentally challenging task, or did a physically demanding exercise before testing their balance.",1.0,1.0,1.0,1.0
Q18_A2,4,"Each session included postural balance assessments around 8 a.m., 12.00 p.m. and 5 p.m. ± 30 min.","Each session had participants tested for balance at around 8 a.m., 12 p.m., and 5 p.m. (+/- 30 minutes).",1.0,1.0,1.0,1.0
Q18_A2,5,The physical and cognitive activities were performed only before the 12 o'clock assessment.,Participants only did the physical and mental activities before the 12 p.m. test.,1.0,1.0,1.0,1.0
Q18_A2,6,The postural tests consisted of four conditions of quiet stance: stance on a firm surface with eyes open; stance on a firm surface with eyes closed; stance on a foam surface with eyes open and stance on a foam surface with eyes closed.,"During the balance tests, participants had to stand in four different positions: standing on a solid surface with their eyes open, standing on a solid surface with their eyes closed, standing on a foam surface with their eyes open, and standing on a foam surface with their eyes closed.",0.0,1.0,1.0,1.0
Q18_A2,7,Postural performance was assessed by various center of pressure (COP) parameters.,We measured how well participants could maintain their balance using different measurements related to the center of pressure.,1.0,1.0,1.0,1.0
Q18_A2,8,"Results: Overall, the COP findings indicated activity-related postural impairment, with an increase in body sway in the most difficult conditions (with foam surface), especially when postural measurements are recorded just after the running exercise (physical session) or the psychomotor vigilance test (cognitive session).","Results: In general, we found that doing an activity before testing balance made it harder for participants to stay stable, especially when they had to stand on a foam surface. This was especially true when they had just finished running or doing a mentally demanding task.",1.0,1.0,1.0,1.0
Q18_A2,9,"Conclusions: Even if no specific influence of time-of-day on static postural control is demonstrated, our results clearly suggest that the activities prior to balance tests could be a potential confounding variable to be taken into account and controlled when assessing clinical postural balance.","Conclusions: While we didn't find a direct effect of the time of day on balance, our results show that the activities done before testing can affect a person's ability to maintain balance. This is important to consider and control for when assessing someone's balance in a clinical setting.",1.0,1.0,1.0,1.0
Q19_A9,1,"Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group of aetiologies, with no single genetic cause.","Lennox-Gastaut syndrome (LGS) is a severe developmental and epileptic condition that starts in childhood. It is caused by a variety of factors, rather than a single genetic cause.",1.0,1.0,1.0,1.0
Q19_A9,2,"It is characterised by multiple seizure types, an abnormal EEG with generalised slow spike and wave discharges and cognitive impairment, associated with high morbidity and profound effects on the quality of life of patients and their families.","LGS is known for causing multiple types of seizures, abnormal brain activity, and cognitive problems. It can have a significant impact on the lives of both patients and their families.",1.0,1.0,1.0,1.0
Q19_A9,3,"Drug-refractory seizures are a hallmark and treatment is further complicated by its multiple morbidities, which evolve over the patient's lifetime.","LGS is known for causing seizures that do not respond well to medication, making treatment difficult. In addition, the condition can lead to various other health problems that change as the patient gets older.",1.0,1.0,1.0,1.0
Q19_A9,4,This review provides a comprehensive overview of the current and future options for the treatment of seizures associated with LGS.,This review will give a detailed look at the current and future treatment options for seizures in LGS.,1.0,1.0,1.0,1.0
Q19_A9,5,"Six treatments are specifically indicated as adjunct therapies for the treatment of seizures associated with LGS in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate and most recently cannabidiol.","In the US, there are six specific treatments that can be used along with other therapies to treat seizures in LGS. These include lamotrigine, clobazam, rufinamide, topiramate, felbamate, and the most recent addition, cannabidiol.",1.0,1.0,1.0,1.0
Q19_A9,6,"These therapies have demonstrated reductions in drop seizures in 15%-68% of patients across trials, with responder rates (≥ 50% reduction in drop seizures) of 37%-78%.","These treatments have shown that they can reduce drop seizures in 15% to 68% of patients in different studies, and about 37% to 78% of patients saw at least a 50% reduction in drop seizures.",0.0,1.0,1.0,1.0
Q19_A9,7,"Valproate is still the preferred first-line treatment, generally in combination with lamotrigine or clobazam.","Valproate is usually the first treatment option for LGS, and it is often used together with lamotrigine or clobazam.",1.0,1.0,1.0,1.0
Q19_A9,8,"Other treatments frequently used off-label include the broad spectrum anti-epileptic drugs (AED) levetiracetam, zonisamide and perampanel, while recent evidence from observational studies has indicated that a newer AED, the levetiracetam analogue brivaracetam, may be effective and well tolerated in LGS patients.","Doctors may also prescribe other medications that are not specifically approved for LGS, such as levetiracetam, zonisamide, and perampanel. Recent studies have suggested that a newer medication called brivaracetam, which is similar to levetiracetam, could be effective and well-tolerated in LGS patients. However, these medications are not yet officially approved for use in LGS.",1.0,1.0,1.0,1.0
Q19_A9,9,"Other treatments in clinical development include fenfluramine in late phase III, perampanel, soticlestat-OV953/TAK-953, carisbamate and ganaxolone.","There are several other treatments being tested in clinical trials for LGS, including fenfluramine, perampanel, soticlestat-OV953/TAK-953, carisbamate, and ganaxolone.",1.0,1.0,1.0,1.0
Q19_A9,10,"Non-pharmacologic interventions include the ketogenic diet, vagus nerve stimulation and surgical interventions; these are also expanding, with the potential for less invasive techniques for corpus callosotomy that have promise for reducing complications.","In addition to medications, there are other treatments available for LGS that do not involve drugs. These include the ketogenic diet, vagus nerve stimulation, and surgical interventions. Researchers are also working on less invasive techniques for a specific type of surgery called corpus callosotomy, which could potentially reduce complications.",0.0,0.0,1.0,1.0
Q19_A9,11,"However, despite these advancements, patients continue to experience a significant burden.","However, even with these improvements in treatment options, LGS patients still face many challenges and difficulties.",1.0,1.0,1.0,1.0
Q19_A9,12,"Because LGS is not a single entity, tailoring of treatment is needed as opposed to a 'one size fits all' approach.","Because LGS is a complex condition with various causes, treatment needs to be customized for each individual instead of using a standardized approach.",1.0,1.0,1.0,1.0
Q19_A9,13,"Further research is needed into the underlying aetiologies and pathophysiology of LGS, together with advancements in treatments that encompass the spectrum of seizures associated with this complex syndrome.","More research is needed to understand the various causes and mechanisms of LGS, as well as to develop better treatments for the different types of seizures associated with this complex syndrome.",1.0,1.0,1.0,1.0
Q20_A7,1,"Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency.",Laron syndrome (LS) is a condition that results in a lack of a hormone called insulin-like growth factor 1 (IGF1) from birth.,1.0,1.0,1.0,1.0
Q20_A7,2,The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical relevance.,"A recent study found that people with Laron syndrome are less likely to develop cancer, which is important for scientists and doctors to know.",1.0,1.0,1.0,1.0
Q20_A7,3,Epidemiological data suggest that congenital IGF1 deficiency confers protection against the development of malignancies.,Data from studies on Laron syndrome suggest that people with a lack of insulin-like growth factor 1 (IGF1) from birth are less likely to develop cancer.,1.0,1.0,1.0,1.0
Q20_A7,4,This 'experiment of nature' reflects the critical role of IGF1 in tumor biology.,This natural occurrence shows how important insulin-like growth factor 1 (IGF1) is in the biology of tumors.,1.0,1.0,1.0,1.0
Q20_A7,5,The present review article provides an overview of recently conducted genome-wide profiling analyses aimed at identifying mechanisms and signaling pathways that are directly responsible for the link between life-time low IGF1 levels and protection from tumor development.,This review article summarizes recent studies that have looked at how low levels of insulin-like growth factor 1 (IGF1) throughout a person's life can protect them from developing tumors. The studies used genome-wide profiling analyses to identify the specific mechanisms and signaling pathways involved in this link.,1.0,0.0,1.0,1.0
Q20_A7,6,The review underscores the concept that 'data mining' an orphan disease might translate into new developments in oncology.,The review emphasizes that studying a rare condition like Laron syndrome can lead to new advancements in the field of oncology.,1.0,0.0,1.0,1.0
Q21_A8,1,"Peripheral neuropathies are characterized by nerves damage and axonal loss, and they could be classified in hereditary or acquired forms.","Peripheral neuropathies are conditions where the nerves in your body get damaged and start to break down. There are different types of peripheral neuropathies, some you inherit from your family and others you develop over time.",1,1,1,1
Q21_A8,2,"Acquired peripheral neuropathies are associated with several causes, including toxic agent exposure, among which the antineoplastic compounds are responsible for the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN).","Acquired peripheral neuropathies can be caused by different things, including exposure to toxic substances. One specific type of acquired peripheral neuropathy is called Chemotherapy-Induced Peripheral Neuropathy (CIPN), which can happen as a result of taking certain cancer medications.",1,1,1,1
Q21_A8,3,Several clinical features are related to the use of anticancer drugs which exert their action by affecting different mechanisms and structures of the peripheral nervous system: the axons (axonopathy) or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy).,"When you take certain cancer medications, they can affect different parts of your nervous system, like the axons or the cells in the dorsal root ganglia. This can cause various symptoms and problems in your body.",1,0,1,1
Q21_A8,4,"In addition, antineoplastic treatments may affect the blood brain barrier integrity, leading to cognitive impairment that may be severe and long-lasting.","In addition, cancer treatments can also affect the protective barrier in the brain called the blood brain barrier. This can lead to cognitive problems that can be serious and long-lasting.",1,0,1,1
Q21_A8,5,CIPN may affect patient quality of life leading to modification or discontinuation of the anticancer therapy.,Chemotherapy-Induced Peripheral Neuropathy (CIPN) can have a big impact on a patient's quality of life and may even cause them to change or stop their cancer treatment.,1,1,1,1
Q21_A8,6,"Although the mechanisms of the damage are not completely understood, several hypotheses have been proposed, among which neuroinflammation is now emerging to be relevant in CIPN pathophysiology.","While we don't fully understand exactly how peripheral neuropathy happens, scientists have some ideas. One theory is that inflammation in the nerves may play a big role in causing Chemotherapy-Induced Peripheral Neuropathy (CIPN).",1,1,1,1
Q21_A8,7,"In this review, we consider different aspects of neuro-immune interactions in several CIPN preclinical studies which suggest a critical connection between chemotherapeutic agents and neurotoxicity.","In this review, we look at various studies on Chemotherapy-Induced Peripheral Neuropathy (CIPN) that suggest a important link between cancer medications and nerve damage, specifically in how the immune system interacts with the nervous system.",1,1,1,1
Q21_A8,8,"The features of the neuroinflammatory processes may be different depending on the type of drug (platinum derivatives, taxanes, vinca alkaloids and proteasome inhibitors).","The way inflammation affects the nerves may vary depending on the specific type of cancer medication being used. Some examples include platinum derivatives, taxanes, vinca alkaloids, and proteasome inhibitors.",1,1,1,1
Q21_A8,9,"In particular, recent studies have demonstrated an involvement of the immune response (both innate and adaptive) and the stimulation and secretion of mediators (cytokines and chemokines) that may be responsible for the painful symptoms, whereas glial cells such as satellite and Schwann cells might contribute to the maintenance of the neuroinflammatory process in DRG and axons respectively.","Recent studies have shown that the immune system, both the innate (automatic) and adaptive (learned) parts, play a role in Chemotherapy-Induced Peripheral Neuropathy (CIPN). The immune response can release certain chemicals, called cytokines and chemokines, which may be responsible for the pain experienced by patients. Additionally, certain cells in the nervous system, like satellite and Schwann cells, might also contribute to the ongoing inflammation in specific parts of the nervous system, such as the dorsal root ganglia (DRG) and the axons.",1,0,1,1
Q21_A8,10,"Moreover, neuroinflammatory components have also been shown in the spinal cord with microglia and astrocytes playing an important role in CIPN development.","Furthermore, research has also shown that inflammation in the spinal cord, specifically involving cells called microglia and astrocytes, is important in the development of Chemotherapy-Induced Peripheral Neuropathy (CIPN).",1,1,1,1
Q21_A8,11,"Taking together, better understanding of these aspects would permit the development of possible strategies in order to improve the management of CIPN.","In conclusion, if we can better understand how inflammation and immune responses contribute to Chemotherapy-Induced Peripheral Neuropathy (CIPN), we can develop strategies to improve how we manage and treat this condition.",1,1,1,1
Q22_A3,1,Chamomile is one of the most ancient medicinal herbs known to mankind.,Chamomile is one of the oldest medicinal herbs that humans have known about.,1,1,1,1
Q22_A3,2,It is a member of Asteraceae/Compositae family and represented by two common varieties viz.,Chamomile belongs to the Asteraceae/Compositae family and there are two common varieties.,1,0,1,1
Q22_A3,3,German Chamomile (Chamomilla recutita) and Roman Chamomile (Chamaemelum nobile).,"The two common varieties of chamomile are German Chamomile, also known as Chamomilla recutita, and Roman Chamomile, also known as Chamaemelum nobile.",1,1,1,1
Q22_A3,4,The dried flowers of chamomile contain many terpenoids and flavonoids contributing to its medicinal properties.,The dried flowers of chamomile have many terpenoids and flavonoids that make it beneficial for medicinal purposes.,1,-1,1,1
Q22_A3,5,"Chamomile preparations are commonly used for many human ailments such as hay fever, inflammation, muscle spasms, menstrual disorders, insomnia, ulcers, wounds, gastrointestinal disorders, rheumatic pain, and hemorrhoids.","Chamomile is often used for various health issues like hay fever, inflammation, muscle spasms, menstrual disorders, trouble sleeping, ulcers, wounds, digestive problems, rheumatic pain, and hemorrhoids.",1,1,1,1
Q22_A3,6,Essential oils of chamomile are used extensively in cosmetics and aromatherapy.,Chamomile essential oils are commonly used in cosmetics and aromatherapy.,1,1,1,1
Q22_A3,7,"Many different preparations of chamomile have been developed, the most popular of which is in the form of herbal tea consumed more than one million cups per day.","There are many different ways to use chamomile, but the most popular is as a herbal tea. People drink over a million cups of chamomile tea every day.",1,1,1,1
Q22_A3,8,"In this review we describe the use of chamomile in traditional medicine with regard to evaluating its curative and preventive properties, highlight recent findings for its development as a therapeutic agent promoting human health.","In this review, we discuss how chamomile has been used in traditional medicine to treat and prevent various ailments. We will also share recent findings on how chamomile can be used as a therapeutic agent to improve human health.",1,0,1,1
Q23_A9,1,"This study aims to introduce a resistance training protocol (6 repetitions × 70% of 1 maximum repetition (1RM), followed by 6 repetitions × 50% of 1RM within the same set) specifically designed for postmenopausal women with osteopenia/osteoporosis and monitor the effect of the protocol on bone mineral density (BMD) in the lumbar spine, assessed by dual-energy X-ray absorptiometry (DEXA).",This study wants to test a new exercise plan for women who have gone through menopause and have weak bones. The plan involves lifting weights in a specific way and then checking how it affects the density of the bones in the lower back using a special type of X-ray.,1.0,1.0,1.0,1.0
Q23_A9,2,"The subjects included in the study were 29 postmenopausal women (56.5 ± 2.8 years) with osteopenia or osteoporosis; they were separated into two groups: the experimental group (n = 15), in which the subjects participated in the strength training protocol for a period of 6 months; and the control group (n = 14), in which the subjects did not take part in any physical activity.","In this study, 29 women who had gone through menopause and had weak bones were included. They were divided into two groups: one group did a special exercise program for 6 months, and the other group did not do any physical activity.",1.0,1.0,1.0,1.0
Q23_A9,3,BMD in the lumbar spine was measured by DEXA.,"To measure the density of the bones in the lower back, a special type of X-ray called DEXA was used.",1.0,1.0,1.0,1.0
Q23_A9,4,The measurements were performed at the beginning and end of the study.,The density of the bones in the lower back was measured before and after the study.,1.0,1.0,1.0,1.0
Q23_A9,5,"A statistically significant increase (Δ% = 1.82%) in BMD was observed at the end of the study for the exercise group (0.778 ± 0.042 at baseline vs. 0.792 ± 0.046 after 6 months, p = 0.018, 95% CI [-0.025, -0.003]); while an increase was observed for the control group (Δ% = 0.14%), the difference was not statistically significant (0.762 ± 0.057 at baseline vs. 0.763 ± 0.059, p = 0.85, 95% CI [-0.013, 0.011]).","At the end of the study, the group that did the exercise program had a significant increase in bone density in the lower back (about 1.82%). The group that did not exercise also had a small increase in bone density (about 0.14%), but it was not statistically significant.",0.0,1.0,1.0,1.0
Q23_A9,6,"In conclusion, our strength training protocol seems to be effective in increasing BMD among women with osteopenia/osteoporosis and represents an affordable strategy for preventing future bone loss.","In conclusion, our exercise program for women with weak bones appears to be effective in improving bone density and can be a low-cost way to prevent further bone loss.",1.0,1.0,1.0,1.0
Q24_A1,1,"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious virus that infects humans and a number of animal species causing coronavirus disease-19 (COVID-19), a respiratory distress syndrome which has provoked a global pandemic and a serious health crisis in most countries across our planet.","SARS-CoV-2 is a really contagious virus that causes COVID-19, a serious illness that affects people's breathing. It has spread all over the world and caused a health crisis.",1,1,1,1
Q24_A1,2,"COVID-19 inflammation is mediated by IL-1, a disease that can cause symptoms such as fever, cough, lung inflammation, thrombosis, stroke, renal failure and headache, to name a few.","COVID-19 causes inflammation in the body, which can lead to symptoms like fever, coughing, lung inflammation, blood clots, stroke, kidney failure, and headaches, among others.",1,1,1,1
Q24_A1,3,Strategies that inhibit IL-1 are certainly helpful in COVID-19 and can represent one of the therapeutic options.,Treatments that block IL-1 can be helpful in treating COVID-19 and may be one option for treatment.,1,0,1,1
Q24_A1,4,"However, until now, COVID-19 therapy has been scarce and, in many cases, ineffective, since there are no specific drugs other than the vaccine that can solve this serious health problem.","So far, there have been few effective treatments for COVID-19. Other than the vaccine, there are no specific drugs that can effectively treat this serious health issue.",1,1,1,1
Q24_A1,5,"Messenger RNA (mRNA) vaccines which are the newest approach, are already available and will certainly meet the many expectations that the population is waiting for.","The newest type of vaccine, called mRNA vaccines, are now available. They are expected to fulfill the high hopes that the population has been waiting for.",1,1,1,1
Q24_A1,6,"mRNA vaccines, coated with protected soft fatty lipids, use genetic mRNA (plus various inactive excipients) to make a piece of the coronavirus spike protein, which will instruct the immune system to produce specific antibodies.","mRNA vaccines use genetic material to create a piece of the coronavirus spike protein, which helps the immune system create antibodies. The vaccine is coated in a protective layer to make it safe and effective.",1,1,1,1
Q24_A1,7,The soft fatty lipids allow the entry of mRNA into cells where it is absorbed into the cytoplasm and initiates the synthesis of the spike protein.,"The protective coating on the vaccine helps it enter cells, where the genetic material is absorbed and prompts the production of the spike protein.",1,1,1,1
Q24_A1,8,"In addition, vaccination also activates T cells that help the immune system respond to further exposure to the coronavirus.","Vaccination also helps activate T cells, which can help the immune system fight off the coronavirus if you come into contact with it again.",1,1,1,1
Q24_A1,9,mRNA induces the synthesis of antigens of SARS-CoV-2 virus which stimulate the antibody response of the vaccinated person with the production of neutralizing antibodies.,The mRNA in the vaccine stimulates the immune system to make proteins that look like parts of the coronavirus. This helps the vaccinated person's body create antibodies that can neutralize the virus.,1,1,1,1
Q24_A1,10,"The new variant of the coronavirus-19 has been detected in the UK where, at the moment, the London government has imposed a lockdown with restrictions on international movements.","A new version of the coronavirus, called the variant, has been found in the UK. Right now, the government in London has put a lockdown in place and has restricted international travel.",1,1,1,1
Q24_A1,11,"The virus variant had already infected 1/4 of the total cases and in December 2020, it reached 2/3 of those infected in the UK.","The variant of the virus has already affected a quarter of the total cases, and by December 2020, it had infected two-thirds of the people who were infected in the UK.",1,1,1,1
Q24_A1,12,"It has been noted that the spreading rate of the British variant could be greater than 70% of cases compared to the normal SARS-CoV-2 virus, with an R index growth of 0.4.","The British variant of the virus spreads more easily than the regular SARS-CoV-2 virus, with a growth rate of 0.4. It may account for up to 70% of cases.",1,0,1,1
Q24_A1,13,"Recent studies suggest that coronavirus-19 variation occurs at the level N501Y of the spike protein and involves 23 separate mutations on the spike, 17 of which are linked to the virus proteins, thus giving specific characteristics to the virus.","Recent studies have found that the variation of the coronavirus-19 involves changes in a specific part of the spike protein called N501Y. There are 23 different mutations on the spike protein, with 17 of them affecting the virus proteins, which gives the virus its unique characteristics.",1,1,1,1
Q24_A1,14,"In general, coronaviruses undergo many mutations that are often not decisive for their biological behavior and does not significantly alter the structure and the components of the virus.","In general, coronaviruses go through many changes, or mutations, but these often don't have a big impact on how the virus behaves or its structure.",0,1,1,1
Q24_A1,15,This phenomenon also occurs in SARS-CoV-2.,This also happens with the SARS-CoV-2 virus.,1,1,1,1
Q24_A1,16,It is highly probable that the variants recently described in the UK will not hinder vaccine-induced immunity.,It is very likely that the variants of the virus found in the UK will not affect the immunity provided by the vaccine.,1,1,1,1
Q24_A1,17,"In fact, the variant will not break the vaccine although it may have some chance of making it a little less effective.","Actually, the variant of the virus won't render the vaccine useless, but it might make it slightly less effective.",1,1,1,1
Q24_A1,18,"Therefore, it is pertinent to think that the vaccine will work against the SARS-CoV-2 variant as well.","So, it's reasonable to believe that the vaccine will still be effective against the variant of the SARS-CoV-2 virus too.",1,1,1,1
Q24_A1,19,"In today's pandemic, the D614G mutation of the amino acid of corronavirus-19, which emerged in Europe in February 2020 is the most frequent form and causes high viral growth.","In the current pandemic, the most common form of the coronavirus-19 mutation is called D614G. It emerged in Europe in February 2020 and leads to rapid viral growth.",1,1,1,1
Q24_A1,20,The previously infrequent D614G mutation is now globally dominant.,"The D614G mutation, which used to be rare, is now the most common form of the virus worldwide.",1,1,1,1
Q24_A1,21,"This variant, which is being tested by many international laboratories, is rapidly spreading across the countries and a series of vaccinated subjects are testing to see if their antibodies can neutralize the new variant of SARS-CoV-2.","This new variant of the virus is spreading quickly in different countries, and researchers are testing to see if people who have been vaccinated are still protected against it. They want to know if the antibodies produced by the vaccine can still fight against this new variant of the SARS-CoV-2 virus.",1,1,1,1
Q24_A1,22,This variant has a very high viral growth and is less detectable with the RT-PCR technique in the laboratory.,This variant of the virus can grow very quickly and is harder to detect in the laboratory using the RT-PCR technique.,1,1,1,1
Q24_A1,23,"It has been reported that the British variant that increases viral load does not cause more severe effects in the respiratory tract and lung disease, therefore, it is certain that the variant is growing rapidly and must be kept under control; for this reason, laboratory data is expected impatiently.","There have been reports that the British variant of the virus, which spreads quickly, does not cause more severe respiratory or lung disease. However, it is still important to keep the variant under control. We are eagerly awaiting laboratory data to learn more about it.",1,1,1,1
Q24_A1,24,The study on the many variants that coronavirus-19 presents is very interesting and complete and clearer data on this topic will be ready in the near future.,The research on the different variants of the coronavirus-19 is fascinating and we will have more detailed information on this topic soon.,1,1,1,1
Q24_A1,25,"In addition, it is still unclear whether the different variants discovered in many countries, including Africa, share the same spike protein mutation and therefore, this is another study to elaborate on.","We still don't know if the different variants of the virus found in many countries, including Africa, have the same mutation in the spike protein. This is something that researchers are still studying.",1,1,1,1
Q24_A1,26,"In order to be certain and to not have unexpected surprises, we need to reduce the spread and the transmission speed of viral variants that could appear around the world, creating new pandemics.","To make sure we're prepared and avoid any surprises, it's important to slow down the spread of viral variants that could lead to new pandemics in different parts of the world.",1,1,1,1
Q24_A1,27,"For this reason, the scientific community is on the alert since laboratory tests on serum antibodies from COVID-19 survivors have been reported to be less effective in attacking the variant.",That's why scientists are paying close attention. They've found that lab tests with antibodies from people who have survived COVID-19 are not as effective at fighting the variant of the virus.,1,1,1,1
Q24_A1,28,"In light of the above, the scientific community must be on the alert as larger variants of the spike protein could escape vaccine-induced antibodies, which for now are of great help to the community and can save millions of lives.","Based on all of this information, it's important for scientists to stay vigilant. The new variants of the virus might be able to evade the antibodies produced by the vaccine, which is currently helping many people and saving lives.",1,1,1,1
Q24_A1,29,Deepening the study of spike protein mutations will help to better understand how to combat coronavirus-19 and its variants.,"By studying the mutations in the spike protein, scientists can learn more about how to fight against coronavirus-19 and its variants.",1,1,1,1
Q25_A1,1,"Experimental, epidemiologic and clinical studies have provided strong evidence that physical exercise has beneficial effects on multiple physiological variables affecting cardiovascular health (lipoprotein levels, rest blood pressure and heart rate, carbohydrate tolerance, neurohormonal activity).","Research studies have shown that physical exercise has many positive effects on our heart health, such as reducing bad cholesterol levels, lowering blood pressure and heart rate, improving how our body processes carbohydrates, and regulating certain hormone activity in our brain.",1,1,1,1
Q25_A1,2,Regular exercise has been shown to slow the progression of cardiovascular disease and to reduce cardiovascular morbidity and mortality.,Regular exercise can help slow down the development of heart disease and decrease the chances of experiencing heart-related illness or death.,1,1,1,1
Q25_A1,3,"More recently, exercise-induced increases in blood flow and shear stress have been observed to enhance vascular function and structure.","New research has found that when we exercise, our blood flow and the friction on our blood vessels increase, which helps improve how our blood vessels function and their overall structure.",1,1,1,1
Q25_A1,4,"By increasing the release of nitric oxide and prostacyclin, shear stress augments endothelium-dependent vasodilation and inhibits multiple processes involved in atherogenesis and restenosis.","When we exercise, our body releases certain chemicals that help widen our blood vessels, allowing for better blood flow. This also helps prevent the buildup of fatty deposits in our arteries and the narrowing of blood vessels.",1,1,1,1
Q25_A1,5,In this review we discuss the underlying mechanisms by which exercise-induced blood flow and shear stress exert their salutary effects on cardiovascular remodeling.,"In this review, we will explore how exercise affects our blood flow and the friction on our blood vessels, and how these changes have positive effects on our heart health.",1,1,1,1
Q26_A2,1,Research on relationships between personality and cognitive abilities has so far resulted in inconsistent findings regarding the strength of the associations.,Studies on the connection between personality and cognitive abilities have produced mixed results in terms of how strong this relationship actually is.,1.0,1.0,1.0,1.0
Q26_A2,2,"Moreover, relationships have rarely been compared longitudinally and bidirectionally between midlife versus late-life cohorts by considering different personality traits as well as multiple cognitive domains over a long-term follow-up period.","Also, very few studies have compared the connections between personality and cognitive abilities over a long period of time, specifically looking at both midlife and late-life groups. Additionally, these studies have considered various personality traits and multiple cognitive areas.",1.0,1.0,1.0,0.0
Q26_A2,3,"We hypothesize that the interplay between the ""Big Five"" personality traits (Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness) and cognitive abilities (information processing speed, crystallized intelligence, fluid intelligence) may change from midlife to old age due to age-associated changes in cognitive and personality plasticity.","We believe that the relationship between the ""Big Five"" personality traits and cognitive abilities may change as people age, due to changes in how the brain and personality develop and change over time. Specifically, we are interested in how traits like Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness interact with different cognitive abilities like information processing speed, crystallized intelligence, and fluid intelligence.",1.0,0.0,1.0,1.0
Q26_A2,4,"We used data from the German Interdisciplinary Longitudinal Study of Adult Development (ILSE study; n = 1,002).","We analyzed information from the German Interdisciplinary Longitudinal Study of Adult Development (ILSE study), which included 1,002 participants.",1.0,1.0,1.0,1.0
Q26_A2,5,"Participants were either born in 1950/52 (midlife sample, n = 502) or in 1930/32 (late-life sample, n = 500) and followed up for up to 12 years.",The participants in our study were either born in 1950 or 1952 (midlife group) or in 1930 or 1932 (late-life group). We followed up with them for a period of up to 12 years.,1.0,1.0,1.0,1.0
Q26_A2,6,"Based on bivariate latent change score regression models (adjusted for gender, education, self-rated and physician-rated health), we observed that, apart from very few exceptions, the intervariable cross-lagged associations between personality traits and cognitive abilities were generally similar between cohorts.","Using statistical models that accounted for factors like gender, education, and health, we found that the connections between personality traits and cognitive abilities were mostly consistent between the midlife and late-life groups, with only a few exceptions.",0.0,1.0,1.0,1.0
Q26_A2,7,"Moreover, in case of neuroticism, extraversion, and openness, the effects of cognitive abilities on change in personality were stronger than the reversed effects.","Furthermore, when it came to traits like neuroticism, extraversion, and openness, we found that cognitive abilities had a stronger impact on changes in personality than the other way around.",0.0,1.0,1.0,1.0
Q26_A2,8,"Our findings thus suggest that the so far predominant perspective of personality in middle adulthood and late-life as a predictor, rather than as an outcome, of cognitive abilities needs more differentiation and reconsideration.",Our findings suggest that the common belief that personality traits in midlife and later life only predict cognitive abilities should be reevaluated. We need to consider that personality traits can also be influenced by changes in cognitive abilities.,1.0,1.0,1.0,1.0
Q27_A1,1,Background: Carpal tunnel syndrome is a common cause of neurological symptomatology.,Background: Carpal tunnel syndrome is a common condition that can cause problems with your nerves.,1.0,1.0,1.0,1.0
Q27_A1,2,Surgical decompression remains the treatment of choice in patients not responding to conservative therapies.,Surgery is recommended for patients with carpal tunnel syndrome who do not find relief from other non-surgical treatments.,1.0,1.0,1.0,1.0
Q27_A1,3,The aim of this study was to assess the effectiveness of standard open decompression by analysis of symptomatic and functional improvement and to assess whether a general surgeon can still perform this operation safely.,The goal of this study was to see if a surgery called open decompression is effective in improving symptoms and function for those with carpal tunnel syndrome. The study also wanted to determine if general surgeons can safely perform this surgery.,1.0,1.0,1.0,1.0
Q27_A1,4,Patients and methods: Patients undergoing standard open carpal tunnel release by a single general surgeon were recruited.,The study included patients who had the standard open carpal tunnel surgery performed by one general surgeon.,1.0,1.0,1.0,1.0
Q27_A1,5,A self-administered Boston questionnaire was used to assess symptom severity and functional status pre- and post-surgical intervention.,Patients completed a questionnaire before and after the surgery to measure the severity of their symptoms and how well they were able to function.,1.0,1.0,1.0,1.0
Q27_A1,6,Results: Forty-seven patients (51 hands) underwent carpal tunnel release and 32 patients completed the questionnaire.,Results: A total of 47 patients (51 hands) had the carpal tunnel surgery and 32 of them filled out the questionnaire.,1.0,1.0,1.0,1.0
Q27_A1,7,"88% had a significant reduction in the symptom severity score, while improvement in function status score was achieved in 79% of patients.","88% of patients experienced a significant decrease in the severity of their symptoms, and 79% showed improvement in their ability to function.",0.0,1.0,1.0,1.0
Q27_A1,8,"Mean symptom severity score improved from 3.41 points preoperatively to 1.85 (p < 0.0001) points at the last follow up examination, while the mean function status score improved from 2.73 to 1.99 points (p < 0.0001).","On average, the severity of symptoms improved from 3.41 to 1.85 after the surgery, and the ability to function improved from 2.73 to 1.99. Both improvements were statistically significant.",1.0,1.0,1.0,1.0
Q27_A1,9,Outcome was poor in six patients with slight worsening of either symptom or function status score.,"Six patients did not have a positive outcome, as their symptoms or ability to function worsened slightly after the surgery.",1.0,1.0,1.0,1.0
Q27_A1,10,Three patients were treated conservatively for minor wound infection without long-term sequelae.,"Three patients received non-surgical treatment for a minor infection at the surgical site, and they did not experience any long-term complications.",1.0,1.0,1.0,1.0
Q27_A1,11,Discussion: Standard open carpal tunnel release still provides efficacious symptomatic relief with a low risk of associated complications when performed by a general surgeon.,Discussion: The standard open carpal tunnel surgery can still effectively relieve symptoms with minimal risk of complications when performed by a general surgeon.,1.0,1.0,1.0,1.0
Q28_A2,1,"A fifty-year-old woman was admitted to our hospital because of generalized edema, progressive symptoms of fatigue and weakness of ten years' duration.","A 50-year-old woman came to our hospital because she had swelling all over her body, was feeling tired all the time, and had been weak for the past 10 years.",1.0,1.0,1.0,1.0
Q28_A2,2,"After an uneventful third delivery, 24 years before admission, she could not lactate and developed oligomenorrhea and then amenorrhea.","After her third delivery went smoothly 24 years ago, she was unable to produce breast milk and then had irregular periods which eventually stopped completely.",0.0,1.0,1.0,1.0
Q28_A2,3,Laboratory evaluation revealed panhypopituitarism and pituitary cell antibodies were positive.,"The lab tests showed that she had a condition called panhypopituitarism, and antibodies were found in her pituitary cells.",1.0,0.0,0.0,1.0
Q28_A2,4,Both CT scans and MR images showed empty sella.,"Both CT scans and MR images showed that her sella (a small, bony structure in the skull) was empty.",1.0,1.0,1.0,1.0
Q28_A2,5,This case is postpartum hypopituitarism without a preceding history of excessive bleeding and may be autoimmune hypophysitis.,"This case is a condition called postpartum hypopituitarism, which means the pituitary gland is not working properly after childbirth. There was no excessive bleeding during childbirth, so it may be caused by an autoimmune disorder called hypophysitis.",1.0,1.0,1.0,1.0
Q29_A1,1,Renal artery stenosis (RAS) is the most common correctable cause of hypertension.,Renal artery stenosis (RAS) is a common condition that can lead to high blood pressure and can be fixed.,1,1,1,1
Q29_A1,2,The current study was undertaken to evaluate the usefulness of color Doppler flow imaging as a screening examination in the detection of significant RAS.,"This study was done to see if using color Doppler flow imaging could help detect significant renal artery stenosis, a common condition that can cause high blood pressure.",1,1,1,1
Q29_A1,3,Fifty-five kidneys in 30 patients were examined with aortography and color Doppler flow imaging in a double-blind fashion.,"In this study, 30 patients had 55 kidneys examined using aortography (a procedure that looks at blood vessels using contrast dye) and color Doppler flow imaging. The study was done in a way that the doctors didn't know the results until later to make it unbiased.",1,1,0,1
Q29_A1,4,"The peak systolic velocity (PSV) in the renal artery, the renal-aortic ratio (RAR) (ie, the ratio of the PSV in the renal artery to the PSV in the aorta), and the renal artery resistive index were determined and compared with the percentage of stenosis as determined with angiography.","The doctors measured the peak speed of blood flow in the renal artery, the ratio of this speed to the speed in the aorta, and the resistive index of the renal artery. They compared these measurements to the amount of blockage in the arteries as seen on angiography (a type of X-ray).",1,1,1,1
Q29_A1,5,Ultrasound (US) criteria used to diagnose RAS were (a) an RAR of 3.5 or greater and/or (b) a renal artery PSV of greater than 100 cm/sec.,"The criteria used during ultrasound to diagnose renal artery stenosis were either a renal-aortic ratio (RAR) of 3.5 or higher, or a peak speed of blood flow in the renal artery greater than 100 cm/sec.",1,1,1,1
Q29_A1,6,Doppler tracings were obtained in 25 (69%) of 36 kidneys with a patent single renal artery.,Doppler tracings were successfully obtained in 25 out of 36 kidneys that had a single open renal artery.,1,1,1,1
Q29_A1,7,RAR and PSV each yielded a sensitivity of 0% in the diagnosis of RAS.,Both the renal-aortic ratio (RAR) and peak systolic velocity (PSV) had a sensitivity of 0% in diagnosing renal artery stenosis (RAS).,0,0,1,1
Q29_A1,8,Doppler tracings were obtained in three (50%) of six occluded renal arteries.,Doppler tracings were successfully obtained in three out of six renal arteries that were completely blocked.,1,1,1,1
Q29_A1,9,"Accessory arteries were present in 13 (24%) of 55 kidneys, but none were visualized with color Doppler flow imaging.","In this study, they found that 13 out of 55 kidneys had extra blood vessels, but these were not able to be seen using color Doppler flow imaging.",1,1,1,1
Q29_A1,10,"The authors conclude that with current technical capability, color duplex US is not an adequate screening method for the detection of RAS.","Based on the results of this study, the authors believe that color Doppler ultrasound is not a good enough test to screen for renal artery stenosis.",1,1,1,1
Q30_A3,1,"The acute onset of purple digits is a concerning manifestation and may represent underlying, potentially life-threatening disease.","If your fingers suddenly turn purple, it could be a sign of a serious underlying illness that could be life-threatening.",1.0,1.0,1.0,1.0
Q30_A3,2,"Correctly identifying the etiology of purple digits is essential to proper management, and can aid in the diagnosis of systemic disease.",It is important to determine the cause of purple fingers in order to treat them correctly and possibly diagnose an underlying health condition.,0.0,1.0,1.0,1.0
Q30_A3,3,Multiple causes of purple digits and significant overlap in clinical presentation can make diagnosis difficult.,Purple fingers can have many different causes and can be challenging to diagnose because the symptoms can be similar for different conditions.,0.0,1.0,1.0,1.0
Q30_A3,4,"Despite the various causes of acute purple digits in the published literature, an algorithmic approach to the evaluation and management of the most common and alarming etiologies has yet to be established.","Even though there are many different reasons for suddenly having purple fingers, there is still no established method for determining the most common and dangerous causes.",0.0,1.0,1.0,1.0
Q30_A3,5,The initial step in evaluating a patient with purple digits is to determine if the cause is associated with hypoxemia or trauma.,The first thing doctors need to do when someone has purple fingers is to figure out if the cause is related to a lack of oxygen or if there has been any injury or trauma.,1.0,1.0,1.0,1.0
Q30_A3,6,"If the patient is in a stable condition, the dermatologist needs to determine if the process could be related to cold exposure such as Raynaud phenomenon, acrocyanosis, pernio, cryoglobulinemia or frostbite.","If the patient is stable, the dermatologist will check if the purple fingers could be due to exposure to cold temperatures, such as Raynaud phenomenon, acrocyanosis, pernio, cryoglobulinemia, or frostbite.",0.0,0.0,1.0,1.0
Q30_A3,7,"If the disease occurs independent of temperature, physical examination and histological evaluation of the skin is recommended.","If the condition is not related to temperature, the doctor will perform a physical examination and a biopsy of the skin may be recommended.",0.0,1.0,1.0,1.0
Q30_A3,8,The lack of peripheral pulses are concerning for acute arterial thrombosis from peripheral vascular disease or arterial embolism.,"If there is a lack of pulses in the fingers, it could be a sign of a serious condition called acute arterial thrombosis or arterial embolism due to peripheral vascular disease.",0.0,0.0,1.0,1.0
Q30_A3,9,"Non-blanching skin changes on the digit that lack inflammation and microthrombosis most likely represent a bleeding or platelet abnormality; however, if microthrombi are identified a more life-threatening processes such as purpura fulminans or embolic phenomenon may be occurring.","If there are skin changes on the fingers that don't go away when pressed and don't show signs of inflammation or blood clotting, it is likely a bleeding or platelet problem. However, if blood clots are found, it could be a more serious condition like purpura fulminans or embolism.",0.0,0.0,1.0,1.0
Q30_A3,10,Evidence of blood vessel inflammation suggests a leukocytoclastic vasculitis.,"If there is inflammation in the blood vessels, it could be a condition called leukocytoclastic vasculitis.",1.0,1.0,1.0,1.0
Q30_A3,11,The patient with a purple blanching digit and normal pulses requires an extensive historical review to help determine the cause.,"If someone has a purple finger that turns white when pressed and has normal pulses, the doctor will need to review their medical history in detail to try to find the cause.",0.0,1.0,1.0,1.0
Q30_A3,12,This review presents an algorithmic approach to assist in the evaluation and management of the purple digit.,This review provides a step-by-step plan to help doctors evaluate and treat purple fingers.,1.0,1.0,1.0,1.0
Q31_A10,1,"Background: Chronic health conditions and polypharmacy are common among the older population and associated with increased risks of adverse events, medicine-interactions, geriatric syndromes, falls and mortality.","Background: Many older people have chronic health problems and take multiple medications, which can lead to more health issues and complications. These may include dangerous reactions between different drugs, problems with balance and movement, and even a higher risk of death.",1,1,1,1
Q31_A10,2,Poor nutrition is also common in older people.,Many older people also struggle with poor nutrition.,1,1,1,1
Q31_A10,3,Causal associations between medication use and older people's nutrient status is seldom discussed.,We don't talk enough about how medication use affects older people's nutrition.,1,1,1,1
Q31_A10,4,"Objectives: The objectives of this review were to summarise the literature reporting associations between medicines commonly prescribed to older adults and nutrient deficiencies, and to discuss the clinical implications and management.","Objectives: The goals of this review were to summarize existing research on the connections between commonly prescribed medications for older adults and nutrient deficiencies, and to discuss how this can impact their health and how it can be managed.",-1,1,1,1
Q31_A10,5,Methods: Medicine information resources (n = 5) were searched for information about nutrient deficiencies associated with common medicines used by older people and listed within the top 50 medicines prescribed by volume on the Australian Pharmaceutical Benefits Scheme.,Methods: We looked at information from five sources about nutrient deficiencies caused by common medications that are frequently prescribed to older adults in Australia.,1,1,1,1
Q31_A10,6,This was followed by a search for clinical studies published on PubMed from inception to April 2020.,This was followed by searching for clinical studies published on PubMed from the beginning until April 2020.,1,1,1,1
Q31_A10,7,"Data was extracted, tabulated and summarised with clinical information relevant to pharmacists and clinicians involved in the care of older people taking medicines.","Data was taken from the studies, organized into tables, and summarized with relevant clinical information for pharmacists and clinicians who work with older people taking medications.",0,1,1,1
Q31_A10,8,Results: A total of 23 clinical studies were identified reporting medicine-induced nutrient deficiencies in older adults.,Results: We found 23 clinical studies that reported cases of nutrient deficiencies caused by medications in older adults.,1,1,1,1
Q31_A10,9,"Vitamin B12, sodium, magnesium were identified as the 3 main nutrients susceptible to deficiency by medicines used to treat cardiovascular disease, neurological conditions, gastrointestinal conditions, and diabetes.","Vitamin B12, sodium, and magnesium were found to be the three main nutrients that can be deficient due to medications used for heart disease, neurological conditions, gastrointestinal problems, and diabetes.",0,0,1,1
Q31_A10,10,The coenzyme CoQ10 was depleted by statins.,Statins can deplete the coenzyme CoQ10.,1,-1,1,1
Q31_A10,11,Conclusion: Certain medicines commonly prescribed to older adults are associated with nutrient deficiencies that may be clinically significant.,Conclusion: Some medications commonly given to older adults can cause nutrient deficiencies that can have important impacts on their health.,1,1,1,1
Q31_A10,12,"Given the high prevalence of comorbidities and polypharmacy it is possible that some of these individual drug-induced nutrient deficiencies are compounded, warranting both clinical and research attention.","Given how common it is for older people to have multiple health problems and take multiple medications, it's possible that the nutrient deficiencies caused by these medications can be made worse. This is something that both doctors and researchers should pay attention to.",0,1,1,1
Q32_A2,1,"Objectives: Interictal epileptiform discharges (IEDs) have been linked to memory impairment, but the spatial and temporal dynamics of this relationship remain elusive.","Objective: We want to understand how abnormal brain activity during periods without seizures, known as interictal epileptiform discharges (IEDs), affects memory. However, we still don't know exactly how these two things are related in terms of where and when they happen in the brain.",1,1,1,1
Q32_A2,2,"In the present study, we aim to systematically characterize the brain areas and times at which IEDs affect memory.","In this study, our goal is to carefully examine and describe the specific parts of the brain and moments in time when interictal epileptiform discharges (IEDs) have an impact on memory.",0,0,1,1
Q32_A2,3,Methods: Eighty epilepsy patients participated in a delayed free recall task while undergoing intracranial electroencephalography (EEG) monitoring.,Methods: We had eighty epilepsy patients take part in a memory test while we monitored their brain activity using a special type of EEG called intracranial electroencephalography.,1,1,1,1
Q32_A2,4,We analyzed the locations and timing of IEDs relative to the behavioral data in order to measure their effects on memory.,"We looked at where and when the abnormal brain activity, or interictal epileptiform discharges (IEDs), happened in relation to the memory test results. This helped us understand how IEDs affect memory.",1,0,1,1
Q32_A2,5,"Results: Overall IED rates did not correlate with task performance across subjects (r = 0.03, p = 0.8).","Results: We found that the frequency of interictal epileptiform discharges (IEDs) happening in the brain did not have a significant relationship with how well participants performed on the memory test. In other words, having more IEDs didn't necessarily mean worse memory performance.",0,0,1,1
Q32_A2,6,"However, at a finer temporal scale, within-subject memory was negatively affected by IEDs during the encoding and recall periods of the task but not during the rest and distractor periods (p < 0.01, p < 0.001, p = 0.3, and p = 0.8, respectively).","However, when we looked at the timing in more detail, we found that within each individual, memory was worse during the periods where interictal epileptiform discharges (IEDs) were happening while they were trying to remember or recall information. However, IEDs didn't have a significant effect on memory during the other parts of the test where they were resting or being distracted.",-1,0,1,1
Q32_A2,7,The effects of IEDs during encoding and recall were stronger in the left hemisphere than in the right (p < 0.05).,The impact of interictal epileptiform discharges (IEDs) on memory was more pronounced in the left side of the brain compared to the right side.,0,0,1,1
Q32_A2,8,"Of six brain areas analyzed, IEDs in the inferior-temporal, medial-temporal, and parietal areas significantly affected memory (false discovery rate < 0.05).","Out of the six areas of the brain that we looked at, we found that abnormal brain activity (interictal epileptiform discharges or IEDs) in the inferior-temporal, medial-temporal, and parietal areas had a significant impact on memory.",-1,0,1,1
Q32_A2,9,Significance: These findings reveal a network of brain areas sensitive to IEDs with key nodes in temporal as well as parietal lobes.,"Overall, this study helps us understand that there are specific parts of the brain that are affected by abnormal brain activity (interictal epileptiform discharges or IEDs) and that these areas play a crucial role in memory. Specifically, we found that the temporal and parietal lobes are particularly important in this network of brain areas.",0,0,1,1
Q32_A2,10,They also demonstrate the time-dependent effects of IEDs in this network on memory.,These findings also show us that the impact of abnormal brain activity (interictal epileptiform discharges or IEDs) on memory depends on the timing within this network of brain areas.,0,0,1,1
Q33_A9,1,"Rationale: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes long-term pulmonary sequelae in adults, but little is known about pulmonary outcomes in pediatrics.",Why do we need to study the long-term effects of COVID-19 on children's lungs?,1.0,1.0,1.0,-1.0
Q33_A9,2,Objective(s): The aim of this study was to describe long-term subjective and objective pulmonary abnormalities after SARS-CoV-2 infection in pediatric populations.,What does this study aim to find out about the lung issues in children who have had COVID-19?,1.0,1.0,1.0,-1.0
Q33_A9,3,"Methods: Single-center, retrospective cohort of patients seen in post-coronavirus disease 2019 (COVID-19) pulmonary clinic in 2021.",How did the researchers conduct this study on children who had COVID-19?,1.0,1.0,1.0,-1.0
Q33_A9,4,Subjects evaluated had persistent pulmonary symptoms 4 weeks or more after initial infection.,The children in the study still had lung symptoms more than 4 weeks after getting COVID-19.,1.0,1.0,1.0,1.0
Q33_A9,5,"Clinical testing included a 6-min walk test (6MWT), chest X-ray, pre- and postbronchodilator spirometry, plethysmography, and diffusion capacity.",What tests did the doctors perform to assess the children's lung health?,1.0,1.0,1.0,-1.0
Q33_A9,6,Patients were followed 2-to-3-months after the initial visit with repeat testing.,The patients came back to the clinic 2 to 3 months later for more tests.,1.0,1.0,1.0,1.0
Q33_A9,7,The primary outcome was the presence of abnormal pulmonary function testing.,The main thing the researchers were looking for was if there were any lung function abnormalities in the children.,1.0,1.0,1.0,1.0
Q33_A9,8,Secondary measures included variables associated with pulmonary outcomes.,The researchers also looked at other factors related to lung health in the children.,1.0,1.0,1.0,1.0
Q33_A9,9,"Results: Eighty-two adolescents were seen at a median of 3.5 months postinfection, with approximately 80% reporting two or more symptoms at clinic presentation (cough, chest pain, dyspnea at rest, and exertional dyspnea).","The researchers saw 82 teenagers about 3.5 months after they had COVID-19, and most of them (around 80%) had two or more symptoms when they came to the clinic, such as cough, chest pain, or difficulty breathing at rest or during exercise.",-1.0,1.0,1.0,1.0
Q33_A9,10,At follow-up (~6.5 months) exertional dyspnea persisted for most (67%).,"When the teenagers came back to the clinic about 6.5 months later, most of them (67%) still had difficulty breathing during exercise.",1.0,1.0,1.0,1.0
Q33_A9,11,"Spirometry was normal in 77% of patients, but 31% had a positive bronchodilator response.","Most of the patients had normal results on the breathing tests (spirometry), but around 31% showed improvement after taking a medication that opens up the airways (bronchodilator).",0.0,1.0,1.0,1.0
Q33_A9,12,No abnormalities were noted on plethysmography or diffusion capacity.,The tests for lung volume and gas exchange did not show any abnormalities in the patients.,1.0,1.0,1.0,1.0
Q33_A9,13,"Clinical phenotypes identified included inhaled corticosteroid responsiveness, paradoxical vocal fold motion disorder, deconditioning, and dysautonomia.","The researchers discovered different types of lung issues in the patients, such as how they responded to a certain medication, abnormal movement of the vocal folds, being out of shape, and problems with the autonomic nervous system.",0.0,1.0,1.0,1.0
Q33_A9,14,"Multivariable modeling demonstrated that obesity, anxiety, and resting dyspnea were associated with reduced 6MWT, while female sex and resting dyspnea were associated with higher Borg Dyspnea and Fatigues scores.","The researchers found that obesity, anxiety, and difficulty breathing at rest were linked to a lower ability to walk for 6 minutes without becoming tired. On the other hand, being female and having difficulty breathing at rest were associated with higher scores for shortness of breath and fatigue.",1.0,1.0,1.0,1.0
Q33_A9,15,Conclusions: This is the largest study to date of pediatric patients with long-term pulmonary sequelae post-COVID-19.,"In this study, researchers looked at a large group of children who had long-term lung issues after COVID-19. This is the biggest study of its kind so far.",1.0,1.0,1.0,1.0
Q33_A9,16,Identified clinical phenotypes and risk factors warrant further study and treatment.,The different types of lung issues and risk factors found in the children need to be studied more and treated appropriately.,1.0,1.0,1.0,1.0
Q34_A5,1,Functional neurologic disorder (FND)/conversion disorder is a prevalent and disabling condition at the intersection of neurology and psychiatry.,Functional neurologic disorder (FND)/conversion disorder is a common and debilitating condition that affects both the brain and mental health.,1,1,1,1
Q34_A5,2,"Clinicians often report feeling ill-equipped treating patients with FND, perpetuated by a historically limited understanding of neurobiologic disease mechanisms.",Doctors often feel unprepared to treat patients with FND due to a lack of understanding about how the disease works in the brain.,1,1,1,1
Q34_A5,3,"In this review, we summarize the neuroimaging literature across the spectrum of sensorimotor FND, including functional imaging studies during rest, sensorimotor performance, and emotional-processing tasks as well as structural magnetic resonance imaging findings.","In this review, we examine the research on brain imaging in patients with sensorimotor FND. This includes studies that look at brain activity during resting, tasks involving movement or sensation, and tasks involving emotions, as well as studies that look at the structure of the brain using magnetic resonance imaging.",1,0,1,1
Q34_A5,4,"Particular attention is given to studies implicating the anterior and middle cingulate cortex and related salience network structures (insula, amygdala, and periaqueductal gray) in the neurobiology of FND.","We focus on studies that show the anterior and middle cingulate cortex, as well as related brain structures like the insula, amygdala, and periaqueductal gray, may play a role in the neurobiology of FND.",0,-1,1,1
Q34_A5,5,"Neuroimaging studies identify cingulo-insular functional alterations during rest, motor performance, and emotion processing in FND populations.","Brain imaging studies have found changes in how the cingulo-insular region of the brain functions when patients with FND are at rest, perform motor tasks, or process emotions.",0,1,1,1
Q34_A5,6,"The literature also supports that patients with FND exhibit heightened amygdalar and periaqueductal gray reactivity to emotionally valenced stimuli, enhanced coupling between amygdalar and motor control areas, and increased amygdalar volumes.","Research also suggests that patients with FND have increased activity in the amygdala and periaqueductal gray areas of the brain when they are exposed to emotionally charged information. They also have stronger connections between the amygdala and areas of the brain responsible for motor control, and their amygdala is larger in size compared to individuals without FND.",1,0,1,1
Q34_A5,7,"The structural neuroimaging literature also implicates cingulo-insular areas in the pathophysiology of FND, though these findings require replication and clarification.","The research on brain structure in patients with FND suggests that the cingulo-insular areas may play a role in the development of the condition, but more studies are needed to confirm and clarify these findings.",0,0,1,1
Q34_A5,8,"While more research is needed to fully elucidate the pathophysiology of FND, salience network alterations appear present in some FND populations and can be contextualized using biopsychosocial models for FND.","While there is still more research to be done to fully understand the causes of FND, changes in the salience network of the brain have been found in some patients with FND. These findings can be better understood by considering the biopsychosocial models of FND.",1,0,1,1
Q35_A8,1,Background: It is critical to developing an accurate method for differentiating between malignant and benign solitary pulmonary nodules.,Background: It is important to find a reliable way to tell the difference between cancerous and non-cancerous growths in the lungs.,1,1,1,1
Q35_A8,2,This study aimed was to establish a predicting model of lung nodules malignancy in a real-world setting.,This study aimed to create a model that can predict whether lung nodules are cancerous or not in real-world situations.,1,1,1,1
Q35_A8,3,"Methods: The authors retrospectively analysed the clinical and computed tomography (CT) data of 121 patients with lung nodules, submitted to percutaneous CT-guided transthoracic biopsy, between 2014 and 2015.",Methods: The authors looked back at the medical and CT scan information of 121 patients who had lung nodules and underwent a procedure called percutaneous CT-guided transthoracic biopsy between 2014 and 2015.,0,1,1,1
Q35_A8,4,Multiple logistic regression was used to screen independent predictors for malignancy and to establish a clinical prediction model to evaluate the probability of malignancy.,They used a statistical method called multiple logistic regression to identify factors that could predict whether a nodule was cancerous or not. They then used these factors to create a model that can estimate the likelihood of a nodule being cancerous.,1,1,1,1
Q35_A8,5,"Results: From a total of 121 patients, 75 (62%) were men and with a mean age of 64.7 years old.","Results: Out of the 121 patients, 75 were men (62%) and the average age was 64.7 years old.",1,0,1,1
Q35_A8,6,"Multivariate logistic regression analysis identified six independent predictors of malignancy: age, gender, smoking status, current extra-pulmonary cancer, air bronchogram and nodule size (p<0.05).","Multivariate logistic regression analysis showed that there were six factors that could independently predict whether a nodule was cancerous or not: age, gender, smoking status, having another type of cancer, air bronchogram, and the size of the nodule.",0,0,1,1
Q35_A8,7,The area under the curve (AUC) was 0.8573.,"The accuracy of the model was measured using a value called the area under the curve (AUC), which was found to be 0.8573.",1,1,1,1
Q35_A8,8,"Conclusions: The prediction model established in this study can be used to assess the probability of malignancy in the Portuguese population, thereby providing help for the diagnosis of lung nodules and the selection of follow-up interventions.",Conclusions: The model created in this study can be used to estimate the likelihood of lung nodules being cancerous in the Portuguese population. This can help doctors make a diagnosis and decide on the appropriate next steps for their patients.,1,0,1,1
Q36_A4,1,"Purpose: As obesity rates continue to climb, the notion that overconsumption reflects an underlying 'food addiction' (FA) has become increasingly influential.","As more and more people become overweight, many believe that overeating may be a sign of a food addiction.",1.0,1.0,1.0,1.0
Q36_A4,2,"An increasingly popular theory is that sugar acts as an addictive agent, eliciting neurobiological changes similar to those seen in drug addiction.","A theory that is gaining popularity suggests that sugar can be addictive, causing changes in the brain similar to those seen in drug addiction.",1.0,1.0,1.0,1.0
Q36_A4,3,"In this paper, we review the evidence in support of sugar addiction.","In this paper, we look at the evidence that supports the idea of sugar addiction.",1.0,1.0,1.0,1.0
Q36_A4,4,"Methods: We reviewed the literature on food and sugar addiction and considered the evidence suggesting the addictiveness of highly processed foods, particularly those with high sugar content.","We looked at studies and research on food and sugar addiction to see if there is evidence that highly processed foods, especially those with lots of sugar, can be addictive.",0.0,1.0,1.0,1.0
Q36_A4,5,We then examined the addictive potential of sugar by contrasting evidence from the animal and human neuroscience literature on drug and sugar addiction.,"Next, we compared evidence from studies on animals and humans to see if sugar can be addictive, similar to drugs.",1.0,1.0,1.0,1.0
Q36_A4,6,"Results: We find little evidence to support sugar addiction in humans, and findings from the animal literature suggest that addiction-like behaviours, such as bingeing, occur only in the context of intermittent access to sugar.","Our findings suggest that there is limited evidence to support the idea of sugar addiction in humans. Studies on animals show that addiction-like behaviors, such as bingeing, only occur when sugar is only available intermittently.",1.0,1.0,1.0,1.0
Q36_A4,7,"These behaviours likely arise from intermittent access to sweet tasting or highly palatable foods, not the neurochemical effects of sugar.","These behaviors are most likely caused by occasional access to tasty or highly enjoyable foods, rather than the effects of sugar on the brain.",1.0,1.0,1.0,1.0
Q36_A4,8,"Conclusion: Given the lack of evidence supporting it, we argue against a premature incorporation of sugar addiction into the scientific literature and public policy recommendations.","In conclusion, we believe it's too soon to start considering sugar addiction as a real problem and making recommendations based on it. There is not enough evidence to support the idea of sugar addiction in humans.",1.0,1.0,1.0,1.0
Q37_A2,1,"When used appropriately, immunization can effectively prevent many infections and diseases.","When given at the right time and in the right way, vaccines can protect you from getting sick with various infections and diseases.",1.0,1.0,1.0,1.0
Q37_A2,2,"Some vaccines, such as that for polio, are believed to produce lifelong immunity.","The polio vaccine, for example, is thought to provide protection against the disease for your whole life.",1.0,1.0,1.0,1.0
Q37_A2,3,"Others, such as those for tetanus and diphtheria, may require that a booster injection be given upon exposure to assure full immunity.",Boosters may be needed for vaccines like tetanus and diphtheria to make sure you stay protected if you come into contact with these diseases.,1.0,1.0,1.0,1.0
Q37_A2,4,"Still others, such as that for influenza, confer immunity for only a limited time.","The flu vaccine, on the other hand, only provides protection for a short period of time.",1.0,1.0,1.0,1.0
Q37_A2,5,"Inoculation is not without risk, particularly in immunosuppressed, allergic, febrile, or pregnant patients.","Getting vaccinated does have some risks, especially for people who have a weak immune system, allergies, a fever, or are pregnant.",1.0,1.0,1.0,1.0
Q37_A2,6,"However, in otherwise healthy patients, serious sequelae are so rare that they are far overshadowed by the enormous benefits of immunization.","But for most healthy people, the chances of having any serious side effects from vaccines are extremely low, and the benefits of getting vaccinated far outweigh any risks.",1.0,1.0,1.0,1.0
Q38_A10,1,Multiple myeloma is an incurable haematological cancer.,Multiple myeloma is a type of blood cancer that cannot be cured.,1.0,1.0,1.0,1.0
Q38_A10,2,The increase in targeted therapies has improved the number of myeloma patients achieving a complete response and improved progression-free survival following therapy.,The development of targeted therapies has increased the number of myeloma patients who experience a complete response and have a longer period of time without the cancer getting worse after receiving treatment.,-1.0,1.0,1.0,1.0
Q38_A10,3,"However, a low level of disease or minimal residual disease (MRD) still persists which contributes to the inevitable relapse in myeloma patients.","However, even though many patients with myeloma respond well to treatment, a small amount of the disease can still remain in the body, leading to a recurrence of the cancer.",0.0,1.0,1.0,1.0
Q38_A10,4,"MRD has been attributed to the presence of dormant myeloma cells and their subsequent reactivation, which is controlled by the microenvironment and specialised niches within the bone marrow.","MRD is caused by dormant myeloma cells in the bone marrow that can become active again, and this is influenced by the surrounding environment in the bone marrow.",1.0,0.0,1.0,1.0
Q38_A10,5,"This contributes to the evasion of the immune system and chemotherapy, eventually leading to relapse.","This allows the cancer cells to avoid being attacked by the immune system and chemotherapy, which eventually leads to the cancer coming back.",0.0,1.0,1.0,1.0
Q38_A10,6,"The growth of myeloma tumours are heavily dependent on environmental stimuli from the bone marrow microenvironment, and this plays a key role in myeloma progression.","The growth of myeloma tumors relies on signals from the bone marrow environment, which is important in the progression of the disease.",0.0,1.0,1.0,1.0
Q38_A10,7,The bone microenvironment also plays a critical role in myeloma bone disease and the development of skeletal-related events.,The bone marrow environment also plays a crucial role in causing bone disease in myeloma and the development of events related to the skeleton.,0.0,1.0,1.0,1.0
Q38_A10,8,This review focuses on the bone marrow microenvironment in relation to myeloma pathogenesis and cancer dormancy.,This review looks at how the bone marrow environment is related to the development of myeloma and the period of time when the cancer is dormant.,0.0,1.0,1.0,1.0
Q38_A10,9,"Moreover, it reviews the current therapies targeting the bone microenvironment to treat myeloma and myeloma bone disease.","Moreover, it discusses the current treatments that target the bone marrow environment to treat myeloma and the bone diseases associated with it.",0.0,1.0,1.0,1.0
Q38_A10,10,"Lastly, it identifies novel therapeutic targets for myeloma treatment and the associated bone disease.","Lastly, it identifies new targets for treatment of myeloma and the bone diseases it causes.",1.0,1.0,1.0,1.0
Q39_A8,1,"Breastfed infants have a growth pattern that is different from formula-fed infants, which is regarded as the optimal growth pattern.","Breastfed babies grow in a different way compared to babies who are given formula, and this way of growing is seen as the best and healthiest.",1.0,1.0,1.0,1.0
Q39_A8,2,"Breastfed infants increase more in weight, length, and BMI during the first 2-3 months of life and then have a slower growth velocity up to 12 months.","Breastfed babies gain more weight, length, and body mass index (BMI) in the first few months of life, but their growth slows down after about a year.",1.0,1.0,1.0,1.0
Q39_A8,3,They also have a higher accumulation of fat during early infancy.,Breastfed babies also tend to have more fat accumulation during their early months.,1.0,1.0,1.0,1.0
Q39_A8,4,"Breastfed infants have lower levels of circulating IGF-I and insulin, which could be part of the explanation of their growth pattern.","Breastfed babies have lower levels of certain hormones in their bodies, like IGF-I and insulin, which may help explain why they grow differently than formula-fed babies.",0.0,1.0,1.0,1.0
Q39_A8,5,Many studies and meta-analyses have examined the association between breastfeeding and later obesity.,Many studies and analyses have looked at the connection between breastfeeding and obesity later in life.,1.0,1.0,1.0,1.0
Q39_A8,6,"Most find a moderate reduction in the risk of later obesity, but it has been argued that this could be biased due to residual confounding and reverse causation.","Most studies show that breastfeeding can slightly decrease the risk of obesity later in life, but some argue that the results may be influenced by other factors and reverse causation.",0.0,0.0,1.0,1.0
Q39_A8,7,"From studies in low- and middle-income countries randomizing women to breastfeeding promotion, there was only little effect on early growth.",Research in low- and middle-income countries that looked at promoting breastfeeding found that it had only a small impact on early growth.,1.0,1.0,1.0,1.0
Q39_A8,8,"Recent studies have found associations between breast milk composition (total fat, protein, human milk oligosaccharides, adiponectin, leptin, and insulin) and growth.","Newer studies have discovered links between the composition of breast milk (such as fat, protein, human milk oligosaccharides, adiponectin, leptin, and insulin) and a baby's growth.",0.0,-1.0,1.0,1.0
Q39_A8,9,"However, the studies are few, and the results are inconsistent.","However, there aren't many studies on this topic, and the results vary.",1.0,1.0,1.0,1.0
Q39_A8,10,"More studies, including studies of maternal factors influencing breast milk composition, are needed to better understand how breastfeeding influences current and later growth and thereby short- and long-term health.","More research is needed to better understand how breastfeeding affects a baby's growth and long-term health, including studying factors that may influence the composition of breast milk.",0.0,1.0,1.0,1.0
Q40_A1,1,"Constipation is a disorder of gastrointestinal motility characterized by difficult or decreased bowel movements, and is a common condition in Western countries.",Constipation is a common condition in Western countries where people struggle with difficult or decreased bowel movements. It happens when the digestive system doesn't move stool properly.,1.0,1.0,1.0,1.0
Q40_A1,2,Laxatives are the most common strategy for managing constipation.,The most common way to manage constipation is by using laxatives.,1.0,1.0,1.0,1.0
Q40_A1,3,"However, long-term use of some laxatives may be associated with harmful side-effects including increased constipation and fecal impaction.","However, using certain laxatives for a long time can have harmful side effects, including making constipation worse and causing fecal impaction.",1.0,1.0,1.0,1.0
Q40_A1,4,"Abdominal massage, once an accepted method of treating constipation, is no longer standard of care, but may be a desirable therapy for this condition because it is inexpensive, non-invasive, free of harmful side-effects, and can be performed by patients themselves.","Abdominal massage used to be a standard way of treating constipation, but it is no longer the preferred method. However, it can still be a good option because it is cheap, doesn't require any surgeries, doesn't have any harmful side effects, and can be done by patients themselves.",1.0,1.0,1.0,1.0
Q40_A1,5,"However, until recently, evidence for its effectiveness was not strong enough to make a recommendation for its use in constipated patients.","However, until recently, there wasn't enough strong evidence to recommend using it as a treatment for constipation.",1.0,1.0,1.0,1.0
Q40_A1,6,"In 1999, Ernst reviewed all available controlled clinical trials, and found that there was no sound evidence for the effectiveness of abdominal massage in the treatment of chronic constipation.","In 1999, a review of all the available controlled clinical trials found that there wasn't enough solid evidence to prove that abdominal massage is effective in treating chronic constipation.",0.0,1.0,1.0,1.0
Q40_A1,7,"This article reviews scientific evidence from 1999 to the present, regarding abdominal massage as an intervention for chronic constipation.",This article reviews the scientific evidence from 1999 until now about using abdominal massage as a treatment for chronic constipation.,1.0,1.0,1.0,1.0
Q40_A1,8,"Since that time, studies have demonstrated that abdominal massage can stimulate peristalsis, decrease colonic transit time, increase the frequency of bowel movements in constipated patients, and decrease the feelings of discomfort and pain that accompany it.","Since then, studies have shown that abdominal massage can help stimulate the movement of the digestive system, speed up the time it takes for stool to pass through the colon, increase the number of bowel movements in constipated patients, and reduce feelings of discomfort and pain that come with constipation.",-1.0,1.0,1.0,1.0
Q40_A1,9,There is also good evidence that massage can stimulate peristalsis in patients with post-surgical ileus.,There is also strong evidence that massage can help stimulate movement in patients who have undergone surgery and are experiencing post-surgical ileus.,0.0,0.0,1.0,1.0
Q40_A1,10,"Individual case reports show that massage has been effective for patients with constipation due to a variety of diagnosed physiologic abnormalities, as well as in patients with long-term functional constipation.","Individual case reports have shown that massage has been effective for patients with constipation caused by different physiological abnormalities, as well as for patients with long-term functional constipation.",-1.0,-1.0,1.0,1.0
